LBPEA01 | HIV-1 pol gene diversity and molecular dating of HIV-1 C from Sri Lanka | E-poster | A1 |
LBPEA02 | Identification and characterization of a CXCR4-tropic transmitted/founder HIV-1 in an acute CRF01_AE infection | E-poster | A3 |
LBPEA03 | Impact of alcohol on HIV infection in hepatocytes | E-poster | A4 |
LBPEA04 | Plasma and antibody glycomic biomarkers predict time to HIV rebound and viral setpoint | E-poster | A22 |
LBPEA05 | Detection of inducible replication competent proviruses in adolescents following early initiation and 14 years of viral suppression in Botswana | E-poster | A22 |
LBPEA06 | CD57 expressing mature NK cells negatively correlate with the level of intact and hypermutated pro-viral DNA in HIV-1 infected ART-suppressed subjects | E-poster | A24 |
LBPEA07 | Estradiol inhibits HIV-1BaL infection and induces expression of CFL1 and LSP1 in endocervical mucosa and in peripheral blood mononuclear cells | E-poster | A30 |
LBPEA08 | Efficacy of on-demand PrEP or PEP with single oral doses of combination tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat (TAF/FTC/EVG/c) in macaques | E-poster | A35 |
LBPEA09 | Viral and immune dynamics in orally SHIV-infected ART-treated infant rhesus macaques | E-poster | A52 |
LBPEA10 | Treatment with the IL-15 superagonist N-803 accelerates time-to-viremia in a novel in vivo humanized mouse model developed for rapid preclinical evaluation of latency reversing agent efficacy | E-poster | A52 |
LBPEB11 | Development and validation of a point-of-care, urine assay to measure adherence to PrEP and ART | E-poster | B11 |
LBPEB12 | Similar 12 & 24 month preliminary outcomes for TRU/DTG and TDF/FTC/EFV regimens in Botswana: The Botswana Epidemiological ART Treatment Cohort Study (The BEAT) | E-poster | B38 |
LBPEB13 | Safety and antiviral activity over 10 days following a single dose of subcutaneous GS-6207, a first-in-class, long-acting HIV capsid inhibitor in people living with HIV | E-poster | B45 |
LBPEB14 | Weight gain during pregnancy among women initiating dolutegravir in Botswana | E-poster | B58 |
LBPEB15 | Low dose efavirenz (Efavirenz 400mg) combined with tenofovir 300mg and lamivudine 300mg shows excellent viral suppression among HIV pregnant women receiving routine HIV care in Zambia | E-poster | B58 |
LBPEB16 | Risk of sexually transmitted infections among women randomized to DMPA-IM, the copper IUD, and levonorgestrel implant in the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial | E-poster | B60 |
LBPEB17 | Early relative effects of intramuscular depot medroxyprogesterone acetate, a copper intrauterine device and the levonorgestrel implant on HIV disease progression: results from the ECHO Trial | E-poster | B60 |
LBPEB18 | Pharmacokinetics (PK) and safety of zidovudine (ZDV), lamivudine (3TC) and lopinavir/ritonavir (LPV/r) in HIV-infected children with severe acute malnutrition (SAM) in sub-Saharan Africa: IMPAACT Protocol P1092 | E-poster | B64 |
LBPEB19 | Emergence of clonal invasive nontypeable Haemophilus influenzae in HIV-positive Black men who have sex with men in Metropolitan Atlanta, 2017-2018 | E-poster | B76 |
LBPEC20 | HIV epidemics to the rise and concentrating in young men in Latin America | E-poster | C1 |
LBPEC21 | Multi-country evaluation of survival and HIV-free survival among children under 3 years of age of women living with HIV in eight sub-Saharan African countries: Results from population-based HIV impact assessments | E-poster | C2 |
LBPEC22 | Persistently high HIV incidence among trans women, San Francisco | E-poster | C4 |
LBPEC23 | High HIV incidence among young women in South Africa: data from the ECHO trial | E-poster | C7 |
LBPEC24 | Modelling progestin-based contraceptive use in high DMPA use and high HIV incidence settings | E-poster | C14 |
LBPEC25 | Integrating oral PrEP delivery into a large HIV endpoint-driven clinical trial in Eastern and Southern Africa: the ECHO trial experience | E-poster | C27 |
LBPEC26 | Virologic assessment of seroconverters in a phase III dapivirine vaginal ring trial | E-poster | C28 |
LBPEC27 | High self-reporting of HIV self-test results through an interactive voice response telephone line in inner city Johannesburg | E-poster | C33 |
LBPEC28 | “It's fast and convenient”: HIVST is highly acceptable to people who inject drugs and their intimate partners in rural and urban settings in Vietnam | E-poster | C33 |
LBPEC29 | Performance of syndromic screening for bacterial STIs among men who have sex with men (MSM) in Dar es Salaam, Tanzania | E-poster | C35 |
LBPEC30 | In utero mother-to-child transmission (MTCT) in Botswana does not differ between efavirenz/tenofovir/emtricitabine (EFV/TDF/FTC) and dolutegravir/tenofovir/emtricitabine (DTG/TDF/FTC) | E-poster | C37 |
LBPEC31 | Results from an impact evaluation of a school-based sexuality and HIV revention education activity in South Africa | E-poster | C54 |
LBPED32 | Effective public-private partnerships for sustainable antiretroviral therapy: Outcomes of the Right to Care Health Services GP down-referral program | E-poster | D2 |
LBPED33 | State licensure laws' relationship to PrEP prescribing by nurse practitioners and physician assistants in the United States, 2017 | E-poster | D3 |
LBPED34 | Oral self-testing for individuals absent or refusing testing during home-based HIV testing - a cluster-randomized trial in Lesotho (HOSENG trial) | E-poster | D12 |
LBPED35 | Temporal relationship between heavy drinking, drug use and antiretroviral medication nonadherence | E-poster | D14 |
LBPED36 | Twelve-month retention and viral load outcomes from a non-inferiority cluster randomized trial extending adherence club ART refill dispensing intervals to 6- monthly | E-poster | D15 |
LBPED37 | HIV self-testing acceptability, feasibility and motivations among young people in South Africa: A demonstration community-based study | E-poster | D30 |
LBPED38 | Strengthening capacity toward the sustainable transition of HIV and TB services to Kenya prisons service | E-poster | D42 |
LBPED39 | Prioritizing continuity of HIV services in Mozambique post cyclone Idai | E-poster | D45 |
LBPED40 | Gaps in the PrEP continuum of care in a large cohort of insured transgender patients | E-poster | D46 |
LBPED41 | Longitudinal cascades more accurately assess health systems performance than cross-sectional cascades such as UNAIDS 90-90-90 targets: A simulation-based demonstration | E-poster | D49 |
LBPED42 | Randomized controlled trial of a positive affect intervention to reduce HIV viral load among methamphetamine-using sexual minority men | E-poster | D64 |
LBPED43 | The impact of memory and substance use on HIV clinic visits | E-poster | D67 |
LBPED44 | Mortality after receipt of short-term incentives for HIV care among adults initiating ART in Tanzania: Follow-up of a randomized trial | E-poster | D106 |
LBPED45 | Is having healthcare coverage enough to increase viral suppression among men who have sex with men in the United States?: Results from HPTN 078 | E-poster | D112 |
LBPED46 | Tolerability, safety and efficacy of MK-8591 at doses of 0.25 to 2.25 mg QD, in combination with doravirine and lamivudine through 24 weeks in treatment-naïve adults with HIV-1 infection | E-poster | B38 |
MOAB0101 | Virologic efficacy of raltegravir vs. efavirenz-based antiretroviral treatment in HIV1-infected adults with tuberculosis: W48 results of the ANRS 12300 Reflate TB2 trial | Oral abstract session with live Q&A | B38 |
MOAB0102 | Week 96 safety and efficacy of the novel HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants infected with multi-drug resistant HIV-1 (BRIGHTE study) | Oral abstract session with live Q&A | B39 |
MOAB0103 | Patient views on long acting HIV treatment: Cabotegravir + rilpivirine as maintenance therapy (ATLAS 48 week results) | Oral abstract session with live Q&A | B45 |
MOAB0104 | Virologic failure In ART-naive HIV patients with high pre-therapy viral load burden initiating on common core agents | Oral abstract session with live Q&A | B40 |
MOAB0105 | Switching to a single-tablet regimen bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) from dolutegravir (DTG) plus emtricitabine and either tenofovir alafenamide or tenofovir disoproxil fumarate (F/TAF or F/TDF) | Oral abstract session with live Q&A | B41 |
MOAB0106 | Longer-term (96-week) efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in women | Oral abstract session with live Q&A | B41 |
MOAB0201 | Impact of rosuvastatin on atherosclerotic progression in people with HIV at moderate cardiovascular risk; A multinational, randomized, double blind, placebo-controlled trial | Oral abstract session with live Q&A | B27 |
MOAB0202 | History of pulmonary opportunistic infection makes no attributable difference to long-term pulmonary function of people living with HIV who smoke | Oral abstract session with live Q&A | B34 |
MOAB0203 | Validation of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV | Oral abstract session with live Q&A | B31 |
MOAB0204 | Assessment of risk factors for hepatocellular carcinoma in HIV care and treatment programs across 31 countries: A cross-sectional survey | Oral abstract session with live Q&A | B13 |
MOAB0205 | Renal function trajectories after switching from TDF to TAF: A nationwide cohort study | Oral abstract session with live Q&A | B29 |
MOAB0206 | Gastrocnemius muscle thickness as a predictor of sarcopenia in people living with HIV | Oral abstract session with live Q&A | B32 |
MOAC0101 | Consumption of recreational drugs and their sexualized use in gay men, bisexual and other men-who-have-sex-with-men from Latin America: Preliminary results of the Latin America MSM Internet Survey (LAMIS) | Oral abstract session with live Q&A | C49 |
MOAC0102 | Polydrug use and HIV sexual risks in a sample of men who inject drugs on the U.S.-Mexico border | Oral abstract session with live Q&A | C53 |
MOAC0103 | Still left behind: Using programmatic data to assess harm reduction service coverage and HIV treatment cascades for people who inject drugs in five South African cities | Oral abstract session with live Q&A | C53 |
MOAC0104 | High levels of depression among Peruvian men who have sex with men: Implications for HIV prevention and treatment care | Oral abstract session with live Q&A | D59 |
MOAC0105 | Gender differences in syringe-related policing behaviors and attitudes following a police education program in Tijuana, Mexico: A longitudinal mixed methods analysis | Oral abstract session with live Q&A | D82 |
MOAD0101 | Policing as a structural determinant of HIV risk among people who inject drugs: A systematic literature review | Oral abstract session with live Q&A | D82 |
MOAD0102 | Witch-hunt in Brazil: Bill 198/2015, criminalization of HIV transmission and pathologization of dissident sexualities | Oral abstract session with live Q&A | D79 |
MOAD0103 | Utilizing individual level data to characterize the relationship between HIV infection and the legal context of sex work across 10 countries in sub Saharan Africa | Oral abstract session with live Q&A | D79 |
MOAD0104 | A pathway to policy commitment for sustainability of a key population-led health services model in Thailand | Oral abstract session with live Q&A | D34 |
MOAD0105 | Barriers and facilitators to the successful transition of adolescents living with HIV from pediatric to adult care in low and middle-income countries: A policy review | Oral abstract session with live Q&A | D62 |
MOAD0201 | Private sector HIV self-testing in Kenya: Insights from a Mystery shopper study | Oral abstract session with live Q&A | D4 |
MOAD0202 | False negative HIV rapid test results among people living with HIV on antiretroviral therapy in Johannesburg, South Africa: Implications for HIV self-testing roll out | Oral abstract session with live Q&A | D10 |
MOAD0203 | Reaching the unreachable: Early results from index testing in Zambia in the CIRKUITS project | Oral abstract session with live Q&A | D12 |
MOAD0204 | “Once their wives are OK
they have no disease:"men infer HIV status from partner's results: Qualitative insights into male HIV testing in rural Malawi | Oral abstract session with live Q&A | D51 |
MOAD0205 | Community mobilization is associated with HIV testing, particularly among men and rural dwellers, in Zambia | Oral abstract session with live Q&A | D58 |
MOAD0301 | PrEP knowledge, intention and uptake among MSM geosocial networking app users in Mexico | Oral abstract session with live Q&A | D96 |
MOAD0302 | Manifestations of stigma in the context of a national oral pre-exposure prophylaxis (PrEP) scale-up program in Kenya | Oral abstract session with live Q&A | D96 |
MOAD0303 | Results from a large Australian PrEP demonstration study: Discontinuation and subsequent HIV and other sexually transmitted infection risk | Oral abstract session with live Q&A | D15 |
MOAD0304 | Predictors of discontinuation in Brazil's free-of-charge PrEP program | Oral abstract session with live Q&A | D96 |
MOAD0305 | A competing risks model for the use of condom in the open-label extension of the ANRS Ipergay study | Oral abstract session with live Q&A | D96 |
MOAD0401 | Are community-led organizations the drivers for enhancing financial security among female sex workers? Lessons from a large-scale HIV intervention in India | Oral abstract session with live Q&A | D8 |
MOAD0402 | Organizational and individual-level strategies associated with viral suppression in a sample of transgender women receiving care for HIV infection in the U.S | Oral abstract session with live Q&A | D84 |
MOAD0403 | Dreams of an AIDS-free generation: Which supportive factors delay onset of adolescent sexual HIV-risk behaviors in South Africa | Oral abstract session with live Q&A | D99 |
MOAD0404 | The Sawa Sawa Intervention: A quazi-experimental trial to reduce community level stigma and improve HIV testing service uptake among men in Sofala Province, Mozambique | Oral abstract session with live Q&A | D109 |
MOAD0405LB | Improving uptake for VMMC in traditional initiation settings | Oral abstract session with live Q&A | D94 |
MOAX0101LB | HPTN 078: primary results of a randomized study to engage men who have sex with men (MSM) living with HIV who are virally unsuppressed in the US | Oral abstract session with live Q&A | B47 |
MOAX0102LB | Progressive rises in weight and clinical obesity for TAF/FTC/DTG and TDF/FTC/DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials | Oral abstract session with live Q&A | B30 |
MOAX0103LB | Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), the levonorgestrel (LNG) implant, and the copper intrauterine device (IUD) | Oral abstract session with live Q&A | B60 |
MOAX0104LB | No occurrences of neural tube defects among 382 women on dolutegravir at pregnancy conception in Brazil | Oral abstract session with live Q&A | B58 |
MOAX0105LB | Neural tube defects by antiretroviral and HIV exposure in the Tsepamo Study, Botswana | Oral abstract session with live Q&A | B58 |
MOAX0106LB | Addressing the safety signal with dolutegravir use at conception: Additional surveillance data from Botswana | Oral abstract session with live Q&A | B58 |
MOPDA0101 | Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir | Poster exhibition | A20 |
MOPDA0102 | Cell-associated HIV RNA and the ratio of HIV RNA to DNA have circadian cycles in HIV-positive individuals on antiretoviral therapy | Poster exhibition | A20 |
MOPDA0103 | Different HIV transcriptional profiles in memory CD4+ T cells subsets during ART | Poster exhibition | A19 |
MOPDA0104LB | Highly sensitive, limiting dilution-multiplex seminested quantitative PCR-based assay reveals a large active HIV-1 reservoir in infected ART-suppressed individuals and elite suppressors | Poster exhibition | A22 |
MOPDA0105LB | CD8+ lymphocyte mediated suppression of HIV expression in CD4+ T cells | Poster exhibition | A20 |
MOPDA0106LB | The inexorability of latent reservoir formation: HIV induces quiescence in effector CD4+ T cells | Poster exhibition | A19 |
MOPDB0101 | Increased levels of current alcohol use are associated with worse HIV care cascade outcomes among HIV-positive adults in rural Kenya and Uganda in the SEARCH trial | Poster exhibition | B36 |
MOPDB0102 | National bio-behavioral surveys suggest improvement in HIV cascade among PWID in Ukraine | Poster exhibition | B77 |
MOPDB0103 | Crystal methamphetamine and group sex fuel an explosive epidemic of hepatitis C among Thai MSM with HIV | Poster exhibition | B18 |
MOPDB0104 | Targeting effective analgesia in clinics for HIV (TEACH): A randomized controlled trial (RCT) to improve satisfaction, confidence, and trust around chronic opioid therapy in HIV care | Poster exhibition | B54 |
MOPDB0105 | Prevalence of recent alcohol and substance use in persons with HIV and associations with HIV care cascade outcomes in South Africa | Poster exhibition | B36 |
MOPDB0106 | Hepatitis C and HIV co-infection and related risk determinants among women who inject drugs in the capital city of Nepal | Poster exhibition | B18 |
MOPDD0101 | Integrating gender-affirming hormone treatment into HIV services facilitates access to HIV testing, syphilis testing, PrEP, and other sexual health services among transgender women in Thailand | Poster exhibition | D23 |
MOPDD0102 | Universal test and treat: Reaching underserved farm workers and their families in four sub-districts of uMgungundlovu District, South Africa | Poster exhibition | D17 |
MOPDD0103 | Cervical cancer screening and treatment cascade for HIV positive women in Zimbabwe: Gaps and opportunities | Poster exhibition | D21 |
MOPDD0104 | Beyond the caregiver: Diffusion of early childhood development knowledge and practices within the social networks of HIV-positive mothers in Malawi | Poster exhibition | D24 |
MOPDD0105 | Feasibility and outcomes of integrating diabetes screening into routine viral load monitoring among patients on antiretroviral therapy in Malawi | Poster exhibition | D21 |
MOPDD0106LB | Tuberculosis preventive therapy in select PEPFAR supported countries | Poster exhibition | D20 |
MOPDD0201 | Sexual health education in a digital savvy adolescent generation: Efficacy of gamified learning in a low-tech setting | Poster exhibition | D100 |
MOPDD0202 | Managing stock levels of HIV commodities using electronic systems in Baylor Uganda, Rwenzori region | Poster exhibition | D19 |
MOPDD0203 | Empowering with PrEP (ePrEP) - a peer-delivered online social network intervention for PrEP adoption among young Black and Latinx men who have sex with men: Cluster randomized controlled trial | Poster exhibition | D19 |
MOPDD0204 | Effectiveness of HIV Telehealth Training Program in increasing the level of knowledge of HIV care personnel in the Philippines: A pilot study | Poster exhibition | D42 |
MOPDD0206 | #endHIVbg: An innovative, targeted national campaign to engage hard-to-reach at-risk MSM and transgender people with a confidential rapid oral home HIV test, in partnership with GrindrTM | Poster exhibition | D81 |
MOPDD0207 | Achieving 96% ARV collection compliance through innovative ATM technology | Poster exhibition | D14 |
MOPEA007 | Dysfunctional natural killer cell subsets correlate with disease progression in HIV-infected Kenyan children | E-poster | A6 |
MOPEA008 | HIV-infected, ART-suppressed intravenous opioid users receiving naltrexone have lower immune activation compared to similar patients receiving methadone | E-poster | A6 |
MOPEA009 | Reduced immune activation and low inflammatory monocyte frequencies during pregnancy are associated with preterm delivery | E-poster | A6 |
MOPEA010 | HLA-F on autologous HIV-infected cells activates primary natural killer (NK) cells expressing the activating killer immunoglobulin-like receptor (KIR) 3DS1 | E-poster | A6 |
MOPEA011 | Toll-like Interleukin-1 Receptor Regulator (TILRR) is a risk factor in vaginal HIV-1 infection through mediating inflammatory response and potentiating the leukocytes chemotaxis | E-poster | A6 |
MOPEA012 | Antibody-bound HIV-1 viruses transmigrate through tissue barriers | E-poster | A7 |
MOPEA013 | CD3+CD8low T cells harbored dysfunctional functions in patients at the earliest stage of HIV infection | E-poster | A8 |
MOPEA014 | Comparative study of subpopulations of B lymphocytes of blood and lymph nodes in the different stages of HIV infection | E-poster | A8 |
MOPEA015 | The expression of immunoregulatory molecules in HIV-specific cells is associated with the activation of CD8 T cells | E-poster | A8 |
MOPEA016 | CD4+ T cells expressing negative checkpoint receptors are associated with decreased mitochondrial oxidative phosphorylation in chronic HIV | E-poster | A8 |
MOPEA017 | Nef genotype influences immune control in HIV-1 infected individuals carrying protective alleles | E-poster | A8 |
MOPEA018 | Phenotype and functionality of CD8+ T cells before and after cART are related to the viral reservoir size in HIV-infected subjects | E-poster | A8 |
MOPEA019 | HIV reservoir size is related to CD4+ and CD8+ T cell differentiation in HCV/HIV-coinfected individuals treated with direct acting antivirals (DAAs) | E-poster | A8 |
MOPEA020 | Women exposed to recent sexual violence show increased inflammatory and decreased anti-HIV biomarkers in the reproductive tract | E-poster | A9 |
MOPEA022 | Methamphetamine Use is associated with increased T cell immune exhaustion in ART treated HIV infected adults | E-poster | A10 |
MOPEA023 | Extracellular vesicle-associated cytokines in HIV-infected human ex vivo tonsils | E-poster | A10 |
MOPEA024 | Primed immature neutrophils in primary and chronic SIV infection, a new player in systemic inflammation | E-poster | A10 |
MOPEA025 | Alteration of inflammatory cytokine levels in gut, despite its systemic normalization with ART in HIV+ patients | E-Poster BU Poster exhibition | A10 |
MOPEA026 | Persistence of “defective” HIV-1 proviruses and markers of immune activation and inflammation in HIV-infected individuals on suppressive combination antiretroviral therapy (cART) | E-poster | A10 |
MOPEA027 | Increased expression of TRAIL receptor DR5 in monocytes and its relationship with serum levels of IL-18 from HIV+ ART naïve patients | E-poster | A11 |
MOPEA028 | Immune activation is associated with poor CD4 reconstitution - A study from South India | E-poster | A11 |
MOPEA029 | Fecal exosomes differentially influence translocating bacterial taxa after SIV infection | E-Poster BU Poster exhibition | A12 |
MOPEA030 | Extracellular vesicles and their microRNA contents are biomarkers of HIV-1 disease progression | E-poster | A13 |
MOPEA031 | Persistent elevation of Tim-3 and PD-1 on memory T cells despite early ART initiation during primary HIV infection | E-poster | A13 |
MOPEA032 | HIV DNA levels, IL28B genotype and CCR5Δ32 among different groups of HIV patients | E-poster | A13 |
MOPEA033 | Serum bone-derived extracellular vesicles are associated with bone loss during antiretroviral therapy in HIV+ individuals | E-poster | A14 |
MOPEA036 | Bystander cell death by pyroptosis of astrocytes requires cell-to-cell transmission of HIV | E-poster | A16 |
MOPEA037 | Plasma brain-derived extracellular vesicles are associated with monocyte activation in individuals with HIV-related cognitive impairment | E-poster | A16 |
MOPEA038 | Production of chemokine fractalkine in HIV brain inflammation: A new approach to understand and treat HIV neuro-pathogenesis | E-poster | A17 |
MOPEA039 | Modeling the cross-talk between HIV-infected microglia and neurons | E-poster | A17 |
MOPEA073 | Immune-phenotypic characteristics associated with an effective acute-phase response predict a reduced amount of integrated HIV DNA in naïve CD4+ T cells in patients treated during acute HIV infection | E-poster | A34 |
MOPEA079 | Vaccine-induced Vif-specific CD8+ T cells exert strong suppressive pressure on acute SIV replication post-infection | E-poster | A38 |
MOPEA080 | Novel gp41 W614A-3S peptide-CRM conjugated vaccine formulated in MF59-like squalene emulsion promotes broadly neutralizing antibodies against HIV-1 | E-poster | A40 |
MOPEA081 | Inflammasome SNPs are associated with risk/protection for tuberculosis and TB-AIDS-immune reconstitution inflammatory syndrome (IRIS) outcomes | E-poster | A44 |
MOPEA082 | Role of active case finding of TB, HIV and HIV TB co-infection case notification amongst infants and children in high risk groups in Zimbabwe | E-poster | A44 |
MOPEA083 | HIV reservoir size is not affected neither by HCV coinfection nor by DAAs therapy | E-poster | A45 |
MOPEA084 | Establishment of anti-hepatitis C virus IgG avidity test for dried serum/plasma spots | E-poster | A45 |
MOPEA085 | HIV infection of hepatitis B virus (HBV)-infected hepatocytes increases CXCL10 production and is associated with liver fibrosis in HIV-HBV co-infected individuals | E-poster | A45 |
MOPEA086 | Immune activation markers associated with levels and diversity of intact HIV proviruses during HIV-HBV co-infection | E-poster | A45 |
MOPEA087 | Low-level detection of HIV DNA in the liver in HIV-HBV coinfected individuals on HBV-active ART | E-poster | A45 |
MOPEA088 | Long-term modification of the HIV reservoir after HCV clearance with direct-acting antivirals (DAAs): The potential role of Ribavirin | E-poster | A45 |
MOPEA089 | Implication and detection of hepatitis B virus immune escape mutants among HIV-infected population group In Southwestern Nigeria | E-poster | A45 |
MOPEA090 | HTLV-1 and HIV-2 co-infections in Cabo Verde | E-poster | A47 |
MOPEA091 | Immunosenescence, thymic output deficiency and mobilization profile of T cell Vβ repertoire are related to relapses of visceral leishmaniasis in HIV-coinfected patients | E-poster | A47 |
MOPEA092 | HIV-1 infection in astrocytes raises intracellular ROS improving Trypanosoma cruzi multiplication | E-poster | A47 |
MOPEA093 | Malnutrition reduces production of IFN-γ among HIV-infected adults initiating ART in Uganda | E-poster | A48 |
MOPEA094 | Evaluating mechanisms of antiretroviral-mediated cardiovascular risk associated with platelet activation | E-poster | A48 |
MOPEA095 | Circulating mitochondrial DNA is higher in acute than in chronic HIV infection and correlates with plasma levels of LPS-binding protein but not of 16S rRNA bacterial DNA | E-poster | A49 |
MOPEB112 | Baseline CD4 count as indicator of success of Test and Treat campaign: Data from the Thai Red Cross Anonymous Clinic, Bangkok, Thailand | E-poster | B1 |
MOPEB113 | Rapid virological suppression at Primary HIV is not associated with long term immune recovery: Results from the HEATHER cohort | E-poster | B1 |
MOPEB114 | Mortality of HIV infection by age, period, disease stage, care cascade and antiretroviral therapy status | E-poster | B4 |
MOPEB115 | Determinants of sub-optimal immune response after antiretroviral therapy initiation in HIV-1 infection | E-poster | B5 |
MOPEB116 | Delay in the attention of virological failure and its impact on mortality in a country with high levels of pretreatment HIV drug resistance | E-poster | B5 |
MOPEB117 | What motivates or prevents frequent HIV testing among young men who have sex with men in New York City? | E-poster | B7 |
MOPEB118 | Viral load assay performs comparably to early infant diagnosis assay to diagnose infants with HIV | E-poster | B7 |
MOPEB119 | “Treat and Test”: Engaging PLHIV for accelerated case detection | E-poster | B7 |
MOPEB120 | Performance, usability and Acceptance of the blood-based INSTI HIV self test in high and low HIV prevalence populations in sub-Saharan Africa | E-poster | B7 |
MOPEB121 | Verification of cobas® c6800/8800 HIV 1/2 qualitative NAT assay for use in South Africa public sector and a new indeterminate range set | E-poster | B7 |
MOPEB122 | Implementing an indeterminate range for more accurate early infant diagnosis: 2018 WHO recommendations | E-poster | B7 |
MOPEB123 | Efficiency of risk assessment tool among Orphans and Vulnerable children to targeted HIV testing services: A case study of Calabar, Nigeria | E-poster | B7 |
MOPEB124 | Field evaluation of Alere HIV Combo to identify acute HIV infection in Lusaka, Zambia | E-poster | B7 |
MOPEB125 | Molecular epidemiology of clinical HIV-1 sequences isolated between 2008-2018 in Cuba | E-poster | B8 |
MOPEB126 | Is it time to change the WHO definition of virologic suppression in the era of HIV epidemic control? 12-month virologic outcomes in patients with WHO defined virologic suppression in Kenya | E-poster | B10 |
MOPEB127 | High prevalence of virologic failure among pregnant and breastfeeding women in HIV care in Kinshasa: First findings in a continuous quality improvement intervention trial | E-poster | B10 |
MOPEB128 | Quantification of HIV1-RNA viral load using automated filtered dried plasma spot, a head-to-head comparison study | E-poster | B10 |
MOPEB129 | HIV viral load suppression among adult patients by time to ART initiation during a pilot of “Test and Start” Nigeria, 2015-2016 | E-poster | B10 |
MOPEB130 | Incidence of viremia events (≥50 copies/ml) among HIV patients with documented viral suppression (< 50 copies/ml) after ART initiation in Ndhiwa, Kenya | E-poster | B10 |
MOPEB131 | Time to switch to second-line antiretroviral therapy among HIV positive people with unsuppressed viral load in Mutare District, Zimbabwe | E-poster | B10 |
MOPEB132 | Use of undetectable viral load to improve estimates of prior HIV diagnosis and antiretroviral treatment coverage among people living with HIV in population-based surveys | E-Poster BU Poster exhibition | B10 |
MOPEB133 | A meta-analysis of using dried blood spots for HIV viral load testing with lower treatment failure thresholds | E-poster | B10 |
MOPEB134 | Incentives conditioned on tenofovir levels to increase adherence among young women on PrEP in Cape Town | E-poster | B11 |
MOPEB135 | A method to quantify dapivirine in small hair samples as a metric of adherence and exposure to the dapivirine vaginal ring | E-poster | B11 |
MOPEB136 | Emerging resistance to integrase inhibitors by next generation sequencing | E-poster | B12 |
MOPEB137 | HIV-1 resistance testing at second-line: Avoiding unnecessary switch to third-line | E-poster | B12 |
MOPEB138 | Can genotyping after second-line ART failure reduce the need for DRV/r-based third-line ART in Kenya? | E-Poster BU Poster exhibition | B12 |
MOPEB139 | Development and evaluation of a low-cost drug resistance test “OLA-Simple” for non-nucleoside-based ART for Mexico's HIV population | E-poster | B12 |
MOPEB140 | High prevalence of drug-resistant HIV-1 among infants newly diagnosed with HIV-1 in Malawi | E-poster | B12 |
MOPEB141 | Validation of PANDAA qDx HIVDR RTI, a simple and scalable real-time PCR-based HIV drug resistance genotyping kit for the management of NNRTI-based ART failure | E-poster | B12 |
MOPEB148 | HIV viral load dynamics and impact on mortality in El Salvador, 2015-2017 | E-poster | B14 |
MOPEB149 | Progressive linear antibodies quantitation decay over time among indiviudals under antiretroviral suppressive treatment; results of SPARC-7 clinical trial | E-poster | B14 |
MOPEB223 | Mortality trends among early ART initiators following implementation of test and start approach at 11 high volume HIV clinics, TASO Uganda | E-poster | B37 |
MOPEB224 | TDF-based regimens: Are they suitable for same-day antiretroviral treatment initiation without baseline laboratory test results in Thailand? | E-poster | B38 |
MOPEB225 | Week 96 resistance and adherence analyses of the once-daily, single-tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in the AMBER and EMERALD phase III trials | E-poster | B38 |
MOPEB226 | Characterization of HIV-1 gag polymorphisms in Ugandan patients failing second line ART | E-poster | B38 |
MOPEB227 | Options for clinically diagnosing cART neurotoxicity in HIV-positive patients | E-poster | B38 |
MOPEB228 | Validation of HIV-ASSIST, an online clinical decision support tool to guide patient-centered ARV regimen selection | E-poster | B38 |
MOPEB229 | Cost-effectiveness of Dolutegravir in HIV-1 treatment-naïve patients in Mexico | E-poster | B38 |
MOPEB230 | Predictors of death in a large cohort of HIV patients in Ukraine | E-poster | B38 |
MOPEB231 | Dolutegravir (DTG) plus lamivudine (3TC) versus DTG plus tenofovir/emtricitabine (TDF/FTC) fixed-dose combination in the GEMINI studies - viral load rebound including 'blips' through 48 weeks | E-poster | B38 |
MOPEB232 | Adoption of 2018 WHO recommendations on preferred first line antiretroviral therapy | E-poster | B38 |
MOPEB233 | Comparing low-dose efavirenz to standard-dose efavirenz and dolutegravir: A systematic literature review and network meta-analysis | E-poster | B38 |
MOPEB234 | A subgroup analysis of the week 96 efficacy and safety results evaluating fostemsavir in heavily treatment-experienced HIV-1 infected participants in the phase 3 BRIGHTE study: Results from the randomized cohort | E-poster | B39 |
MOPEB235 | Long-term outcomes in a large randomized trial of HIV Salvage therapy: 96-week final results of AIDS clinical trials group study A5241 (OPTIONS) | E-poster | B39 |
MOPEB236 | Identifying heavily treatment-experienced patients in a large administrative claims database | E-poster | B39 |
MOPEB237 | Impact of archived M184V/I mutations on the effectiveness of switching to coformulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide among virologically suppressed HIV-positive patients | E-poster | B41 |
MOPEB238 | A Phase 3b, multicenter, open-label study switching from an Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide(E/C/F/TAF) or a Tenofovir disoproxil fumarate containing regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in virologically-suppressed, HIV-1 infected subjects aged ≥65 years | E-poster | B41 |
MOPEB239 | Discontinuation of long-term dolutegravir treatment is associated with UGT1A1 gene polymorphisms | E-poster | B42 |
MOPEB240 | Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients with suspected meningitis in Uganda | E-poster | B43 |
MOPEB241 | Keeping the pressure on archived NRTI resistance: Switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) triple therapy in study 4030 | E-poster | B44 |
MOPEB242 | Low-frequency resistance variants in ART-naïve participants do not affect bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) triple therapy treatment outcome | E-poster | B44 |
MOPEB243 | Previously undocumented preexisting resistance and maintenance of virologic suppression in HIV-1 RNA-suppressed patients switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) | E-poster | B44 |
MOPEB244 | Impact of patient characteristics on integrase resistance | E-poster | B44 |
MOPEB245 | Pre-treatment and acquired HIV drug resistance in Vietnam: Results from a nationally representative survey | E-poster | B44 |
MOPEB246 | Prevalence of heavily treatment-experienced persons with HIV in the United States, 2000-2017 | E-poster | B44 |
MOPEB247 | Impaired genotypic resistance interpretation due to HIV-1 variant specific markers | E-poster | B44 |
MOPEB248 | National survey of pre-treatment HIV drug resistance in Cuban patients | E-poster | B44 |
MOPEB249 | Differential detection of M184V/I between plasma historical HIV genotypes and proviral DNA from PBMCs | E-poster | B44 |
MOPEB250 | High level of HIV-1 drug resistance among first-line failures in three health facilities in Tete province and Maputo city, Mozambique | E-poster | B44 |
MOPEB251 | Analysis of HIV type 1 subtypes C p6gag sequences for PTAP motif duplication and PYXE insertion | E-poster | B44 |
MOPEB252 | Primary resistance to integrase inhibitors among recombinants in Kinshasa using DBS | E-poster | B44 |
MOPEB253 | Archived HIV drug resistance in naïve, suppressed and non-suppressed Indian patients | E-Poster BU Poster exhibition | B44 |
MOPEB254 | Integrase strand transfer inhibitor (INSTI) transmitted drug resistance in the Philippines: Implications for the coming shift to first-line INSTI-based antiretroviral therapy | E-Poster BU Poster exhibition | B44 |
MOPEB255 | High level of pre-treatment HIV-1 drug resistance in a rural and an urban settings in Mozambique | E-poster | B44 |
MOPEB256 | Interest in and preferences for multipurpose technology for combined contraception and antiretroviral therapy and non-oral antiretroviral therapy among women living with HIV in western Kenya | E-poster | B45 |
MOPEB257 | Monthly long-acting cabotegravir and rilpivirine is non-inferior to oral ART as maintenance therapy for HIV-1 infection: Week 48 pooled analysis from the Phase 3 ATLAS and FLAIR studies | E-poster | B45 |
MOPEB258 | Patient reported outcomes on long-acting Cabotegravir + Rilpivirine as maintenance therapy: FLAIR 48 week results | E-poster | B45 |
MOPEB259 | Characteristics and health service utilization of key populations living with HIV in Nigeria recruited through facility-based services versus outreach services | E-poster | B46 |
MOPEB260 | Real-time antiretroviral electronic adherence monitoring in young African American MSM: Information for intervention development | E-poster | B46 |
MOPEB261 | Do clinic transfers lead to gaps in clinical care? Evidence from a large cohort of HIV-infected adults in South Africa | E-poster | B46 |
MOPEB262 | High rates of viral load suppression among patients participating in a home-based, nurse-led ART adherence support intervention in Kazakhstan, Kyrgyzstan and Tajikistan | E-poster | B47 |
MOPEB263 | A pilot test of biometric fingerprint scanning to monitor engagement in HIV care for women in Option B+ | E-poster | B47 |
MOPEB264 | Assessing the facilitators and barriers of antiretroviral therapy adherence among key populations (KP) in Mumbai, India: A way forward for designing KP-centric adherence interventions | E-poster | B47 |
MOPEB265 | Long-term virologic responses to antiretroviral therapy among patients entering adherence clubs in Khayelitsha, Cape Town, South Africa | E-poster | B47 |
MOPEB266 | Antiretroviral therapy adherence and viral suppression in HIV-infected population; A case study of Coast General Hospital, Mombasa County-Kenya | E-poster | B47 |
MOPEB267 | Is DTG+3TC and DTG+RPV effective and safe in clinical practice? Evidence from real world data | E-poster | B49 |
MOPEB268 | Seminal HIV-1 RNA and drug concentrations in DTG+3TC dual therapy (ANRS167 LAMIDOL) | E-poster | B49 |
MOPEB269 | A switch to dolutegravir in combination with boosted darunavir is safe and effective in suppressed patients with HIV - a subanalysis of the dualis study | E-poster | B49 |
MOPEB270 | Improved case detection and management of advanced HIV disease through TB contact risk stratification and implementation of a package of interventions in a rural district of Mozambique | E-poster | B49 |
MOPEB271 | Engagement in care and viral suppression 2 years after home-based same-day ART initiation in Lesotho: 24-months outcomes of CASCADE trial | E-poster | B49 |
MOPEB272 | The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection | E-poster | B52 |
MOPEB273 | The FRESH acute HIV cohort: Optimized for an HIV cure intervention | E-poster | B52 |
MOPEB274 | No evidence of neuroaxonal injury following latency reversal with vorinostat and HIV-1 specific vaccination in the RIVER trial | E-poster | B52 |
MOPEB275 | Clinical and economic impact of ibalizumab for patients with multidrug-resistant HIV in the United States | E-poster | B53 |
MOPEB276 | Malnutrition treatment outcomes of patients receiving RUTF vs peanut butter and fortified blended flour in Mwanza, Tanzania | E-poster | B55 |
MOPEB277 | Household food insecurity and nutritional status of HIV-positive individuals on ART in Lesotho | E-poster | B55 |
MOPEB278 | The effects of aerobic exercises on inflammatory markers and depression in people living with HIV undergoing the highly active antiretroviral therapy: A systematic review with meta-analysis | E-poster | B56 |
MOPEC317 | Effect of strategic Index case testing on HIV case detection in Nigeria: APIN experience | E-poster | C1 |
MOPEC318 | HIV care in Turkey: How far Is the UNAIDS 90-90-90 goals? | E-poster | C1 |
MOPEC320 | Inference of time interval between HIV-1 infection and diagnosis during 2005-2015 in Greece: Implications for testing and control of HIV-1 | E-poster | C1 |
MOPEC321 | Mortality and loss to follow-up in HIV-positive patients starting ART in rural northern Mozambique: The impact of incorporating tracing outcomes on estimates of incidence and associations | E-poster | C1 |
MOPEC322 | Gender features of HIV care cascade in 7 countries of Eastern Europe and Central Asia | E-poster | C1 |
MOPEC323 | Where do we stand after 4 years of option B+? Community HIV-prevalence and mortality in HIV-exposed children under 4 years in rural southern Mozambique | E-poster | C2 |
MOPEC324 | Incidence rate and predictors of HIV incidence among adolescent girls and young women in Lilongwe, Malawi | E-poster | C2 |
MOPEC325 | Developmental trajectories of transactional sex and age-disparate relationships during adolescence: An HPTN 068 analysis | E-poster | C2 |
MOPEC326 | Vertically-infected adolescents have poor viral suppression compared to horizontally-infected youth | E-poster | C2 |
MOPEC327 | Divergent HIV diagnosis rates among Australian- and Asian-born men who have sex with men: Evidence of inequitable access to HIV prevention? | E-poster | C3 |
MOPEC328 | Profile and HIV prevalence among young men who have sex with men in India: Findings from a large-scale multi-centric cross-sectional surveillance survey | E-poster | C3 |
MOPEC329 | HIV prevalence and incidence among men who have sex with men (MSM) attending HIV testing and counselling at a community health care center, Kuala Lumpur, Malaysia 2014-2017 | E-poster | C3 |
MOPEC330 | HIV testing practices and reasons for never-testing among men who have sex with men (MSM) in Malaysia | E-poster | C3 |
MOPEC331 | Neglected population? HIV and other STIs burden among transgender people in Nairobi, Kenya | E-poster | C4 |
MOPEC332 | Characterizing the HIV treatment cascade among transgender women in Kigali, Rwanda | E-poster | C4 |
MOPEC333 | Evaluating differential HIV prevention and treatment outcomes between transgender women and cisgender men who have sex with men in urban centres across Cameroon | E-poster | C4 |
MOPEC334 | A highly-connected risk network position was associated with recent HIV infection approximately three years after the large HIV outbreak began among people who inject drugs (PWID) in Athens | E-poster | C5 |
MOPEC335 | HCV, HIV/HCV co-infection among people injecting drugs in Tanzania: A hidden epidemic | E-poster | C5 |
MOPEC336 | HIV prevalence, HIV testing and unrecognized infection among young female sex workers in India: Findings from a large-scale multi-centric cross-sectional surveillance survey | E-poster | C6 |
MOPEC337 | Progress toward UNAIDS 90-90-90: Experiences from female sex workers in Nigeria | E-poster | C6 |
MOPEC338 | HIV risk behavior and testing among people living with sensory disabilities in the United States | E-poster | C7 |
MOPEC339 | HIV epidemiology among the Fisherfolk in the Islands of Lake Victoria in Western Kenya: 2017-2018 | E-poster | C7 |
MOPEC340 | Crystal amphetamine use is common and is associated with HIV infection among MSM and TGW in Bangkok, Thailand | E-poster | C8 |
MOPEC341 | Determinants of mother to child transmission of HIV among women on the PMTCT programme in Mwenezi district of Masvingo province, Zimbabwe | E-poster | C8 |
MOPEC342 | Intimate partner violence and incident HIV among adolescent girls and young women in rural South Africa: HPTN 068 | E-poster | C8 |
MOPEC343 | The connection between drug use and risk-taking attitudes and behaviors in the context of HIV/STI Epidemic in China - findings from a 2018 Survey of MSM in China | E-poster | C8 |
MOPEC344 | Male partner age and HIV infection among young women in cohabitating partnerships in five countries in southern Africa | E-poster | C8 |
MOPEC345 | A systematic review of risk factors for HIV acquisition during pregnancy and breastfeeding in sub-Saharan Africa | E-poster | C8 |
MOPEC346 | Analysis of HCV co-infections among newly diagnosed HIV cases in Germany | E-poster | C9 |
MOPEC347 | Knowledge and attitudes around syphilis and syphilis pre-exposure prophylaxis (PrEP) among men who have sex with men in Vancouver, Canada: A qualitative study | E-poster | C9 |
MOPEC348 | Genetic network analysis to assess the risk of HIV transmission among MSM seeking partners on the internet | E-poster | C10 |
MOPEC349 | Detecting outbreak cases in men who have sex with men of a specific age group in Japan by the Search Program of HIV Nation-wide Cluster using Sequence (SPHNCS) | E-poster | C10 |
MOPEC350 | Characterizing the changing circulating HIV-1 strains in the Philippines to better understand the ongoing epidemic | E-poster | C10 |
MOPEC351 | Analysis of molecular transmission clusters among newly diagnosed HIV patients in Republic of Panama 2016-2018 | E-poster | C10 |
MOPEC352 | Occupational PrEP for young men who have sex with men and transgender women who exchange sex: Development and implementation of an effectiveness and adherence support open-label study in Bangkok, Thailand | E-poster | C11 |
MOPEC353 | Alternative RCT designs for microbicides and on-demand HIV prevention products | E-poster | C11 |
MOPEC354 | Privacy, confidentiality, and informed consent for HIV phylogenetic research: A case study of urban individuals living with HIV approached for enrollment in an HIV study | E-poster | C12 |
MOPEC355 | Conflicting ethical and legal obligations in adolescents HIV prevention research in low resource settings: Medical Research Council of Zimbabwe Ethics Committee Experiences | E-poster | C12 |
MOPEC356 | Beyond U=U: Reducing AIDS mortality further accelerates declines in HIV incidence | E-poster | C14 |
MOPEC357 | Potential utility of routine programmatic data in monitoring national and state-level HIV epidemic in Nigeria: Data triangulation analysis | E-poster | C14 |
MOPEC358 | Impact of targeted pre-exposure prophylaxis uptake among male sex workers on HIV incidence among men who have sex with men: An agent-based modeling study | E-poster | C14 |
MOPEC359 | Cost-effectiveness of HIV antiretroviral treatment scale-up among overlapping key populations in Tijuana, Mexico | E-poster | C14 |
MOPEC360 | Optimal allocation of HIV resources in geographically heterogeneous epidemics | E-poster | C14 |
MOPEC361 | The status quo won't suffice: Modeled projections of the HIV/AIDS epidemic across 6 US cities | E-poster | C14 |
MOPEC362 | The impact of expanding opioid agonist therapies on HIV epidemic and mortality in Ukraine: A modeling study | E-poster | C14 |
MOPEC363 | Factors associated with access to antiretroviral treatment and viral suppression among HIV+ Latin American MSM: Preliminary results of the Latin-American Men Internet Survey (LAMIS) | E-poster | C15 |
MOPEC364 | Trends in late diagnosis of HIV and time to viral suppression among gay, bisexual and other men who have sex with men (GBM) in Melbourne, Australia | E-poster | C15 |
MOPEC365 | Late diagnosis of HIV new infections in Chile | E-poster | C15 |
MOPEC366 | Comparison of key findings of the 2013-2014 and 2018 bio-behavioral surveys amongst female sex workers in South Africa | E-poster | C15 |
MOPEC367 | Migration and mobility: Correlates of recent HIV testing among female sex workers at the Mexico-Guatemala border | E-poster | C15 |
MOPEC368 | Results from a bio-behavioral survey among female sex workers in South Africa: High HIV prevalence and low uptake of HIV-related health services | E-poster | C15 |
MOPEC369 | Sero-prevalence of human immunodeficiency virus and syphilis among pregnant women attending antenatal clinics in Tanzania: Results from ANC sentinel surveillance 2017/2018 | E-poster | C15 |
MOPEC370 | Prevalence and factors associated with virologic suppression among adults and children living with HIV in Lake Victoria island fishing communities in Kenya, 2017/2018 | E-poster | C15 |
MOPEC371 | Partner notification services as a strategy to identify HIV-positive contacts of female sex workers, western Kenya | E-poster | C16 |
MOPEC372 | A fast track post-exposure prophylaxis (PEP) service delivery model for Thai men who have sex with men (MSM): A prevention opportunity for PEP to pre-exposure prophylaxis (PrEP) transition | E-poster | C17 |
MOPEC373 | Incidence in pregnant women attending antenatal clinics in western Kenya | E-poster | C18 |
MOPEC374 | Inference of the HIV infection dates in Greece using a dense sampling of molecular sequences | E-poster | C18 |
MOPEC375 | Using routinely collected data to measure HIV-incidence in high risk populations | E-poster | C18 |
MOPEC376 | Exploring differences in empirical incidence data in South African surveys using an agent-based network model | E-poster | C19 |
MOPEC377 | Sustained, low prevalence of undiagnosed HIV among gay and bisexual men in Sydney, Australia coincident with increased testing and PrEP use: Results from repeated, bio-behavioural studies 2014-2018 | E-poster | C19 |
MOPEC378 | HIV prevention strategies in Barcelona's Latin American migrants: 68% reduction in incidence reported by BCN Checkpoint | E-poster | C20 |
MOPEC379 | Promising shifts in HIV risk factors and service uptake among young men in Eswatini | E-poster | C20 |
MOPEC380 | Vertical transmission in the Rwanda PMTCT Cascade: A cross sectional study of HIV-infected children in 2017-2018 | E-poster | C20 |
MOPED528 | Patterns of substance use screening in HIV primary care clinics | E-poster | D1 |
MOPED529 | Achieving HIV epidemic control in Zambia: Improving treatment and viral load monitoring coverage in Lusaka urban district through a 'Surge' campaign | E-poster | D1 |
MOPED530 | Retention in non-facility-based ART delivery models among stable ART patients in Lusaka, Zambia: Findings from the HPTN 071 (PopART) trial | E-poster | D2 |
MOPED531 | Centralized dispensing and alternative pick up points increase access to ARVs in Zambia | E-poster | D2 |
MOPED532 | Differentiated ART delivery for key populations: A systematic review | E-poster | D2 |
MOPED533 | Community Adherence Group (CAG) for HIV viremic patients: Early lessons learnt from Lusaka, Zambia | E-poster | D2 |
MOPED534 | Differentiated antiretroviral therapy delivery: A review of implementation progress and challenges in Zimbabwe | E-poster | D2 |
MOPED535 | Back to basics: Friendly health providers are the key to retaining adolescents living with HIV | E-poster | D3 |
MOPED536 | Improved 12-month ART retention rates through intensive monitoring of key process measures in Zambézia province, Mozambique | E-poster | D4 |
MOPED537 | Implementing quality improvement in a large HIV clinic to improve the availability of pediatric viral load results for patient care in rural Zambézia, Mozambique | E-poster | D4 |
MOPED538 | Achieving the “third 90” in western Kenya: A quality improvement collaborative (QIC) to improve viral load utilization at 30 health facilities in Siaya County, Kenya | E-poster | D4 |
MOPED539 | Differentiated Service Delivery (DSD) implementation fidelity: Improving coverage and quality of DSD ART delivery in Zimbabwe | E-poster | D4 |
MOPED540 | A change package for facilitating rapid initiation of ART and early retention in care from a Quality Improvement Collaborative | E-poster | D4 |
MOPED541 | A quality improvement collaborative (QIC) approach to improve early infant diagnosis (EID) and antiretroviral therapy (ART) initiation at 25 health facilities in Lusaka urban district, Zambia | E-poster | D4 |
MOPED542 | Suppressed viral load among persons on antiretroviral therapy - A case for clinical judiciousness and comprehensive monitoring for persons living with HIV | E-poster | D4 |
MOPED543 | Engagement of peer navigators in the multidisciplinary team of providers in the same-day antiretroviral therapy initiation hub model in Bangkok, Thailand | E-poster | D4 |
MOPED544 | Optimizing treatment models for people living with HIV in urban Zimbabwe: Findings from a mixed methods study | E-poster | D4 |
MOPED545 | Peer supporters a crucial prong in the HIV response: Perspectives of health providers | E-poster | D5 |
MOPED546 | Systematic review of the evidence regarding the effectiveness of community-based primary health care in improving HIV/AIDS outcomes for mothers and children | E-poster | D5 |
MOPED547 | Game changer partnerships with non-HEALTH - Civil Society Organizations critical for reaching 90-90-90 | E-poster | D5 |
MOPED548 | Innovative demand creation changes in rolling out oral pre-exposure prophylaxis (PrEP) in Kenya - the Jilinde experience | E-poster | D6 |
MOPED549 | The student resource centre model and its impact on student access to HIV related services: A case of Mutare Teachers' College, Mutare, Zimbabwe | E-poster | D6 |
MOPED550 | A culturally sensitive online communication strategy to reach men who have sex with men (MSM) for HIV/STI prevention and testing in South Korea | E-poster | D6 |
MOPED551 | Community-led demand creation approaches to improve uptake of safe voluntary medical male circumcision in Eastern Uganda | E-poster | D6 |
MOPED552 | Leveraging interprofessional student collaboration to educate healthcare providers and increase access to pre-exposure prophylaxis: Results of a novel educational approach | E-poster | D7 |
MOPED553 | Results from a community mentor mother-led case management of children living with HIV: A case study of USAID's Nilinde Project | E-poster | D8 |
MOPED554 | Reasons why parents are reluctant to disclose their HIV positive status to their children: Lesson learnt in Botswana | E-poster | D8 |
MOPED555 | Elimination by the people: A community led approach towards elimination of mother to child transmission of HIV & syphilis. Experience from Global Fund supported Ahana project in India | E-poster | D8 |
MOPED556 | Effects of malnutrition on ART adherence. Findings from a community HIV project in Botswana | E-poster | D8 |
MOPED557 | Standardization of the services provided in HIV from the community, registration, monitoring and evaluation of these within the framework of the Colombian health system, as strategy for maintaining the response | E-poster | D8 |
MOPED558 | High uptake and completion of HIV self-testing using a novel community-based delivery strategy for young people in Kenya | E-poster | D8 |
MOPED559 | Demonstration project of the First Community Led Transgender clinic in the Philippines (Manila) | E-poster | D8 |
MOPED560 | Impossible to become possible: A journey towards EMTCT; result from plan India's Global Fund supported Ahana project in 9 states of India | E-poster | D8 |
MOPED561 | Female volunteer community advocates perform at a comparable level with their male counterparts supporting voluntary medical male circumcision (VMMC) services at routine facilities in Tanzania | E-poster | D8 |
MOPED562 | Tapping into and maximizing the use of faith worship centers as entry point to HIV prevention services: The experience of Health Kiosk model in Zimbabwe | E-poster | D8 |
MOPED563 | Provider and client-led partner notification service (PNS) approaches on HIV case identification in Zambia | E-poster | D9 |
MOPED564 | Community-led assessment of awareness and willingness of HIV self-screening among men who have sex with men (MSM) and transgender women (TGW) in the Philippines | E-poster | D9 |
MOPED565 | Community-led conversations on awareness and acceptability of HIV self-screening among men who have sex with men and transgender women in metropolitan Manila, Philippines | E-poster | D9 |
MOPED566 | Improving PrEP research with transgender women: Lessons from a social network adherence trial in Peru | E-poster | D9 |
MOPED567 | Correlates of missed visits by participants enrolled in a HIV prevention clinical trial in Eldoret Kenya | E-poster | D9 |
MOPED568 | Organizational structure of the HIV care continuum in Mexico: A social network analysis | E-poster | D10 |
MOPED569 | Using expert patients to Scale up HIV Viral Load testing in resource limited settings in United Republic of Tanzania | E-poster | D10 |
MOPED570 | I-SURGE, a new implementation strategy to optimize HIV services in Luanda, Angola | E-poster | D10 |
MOPED571 | Effects of the community responses program on HIV testing and treatment for men and women: Findings from a randomized controlled trial in informal settlements in KwaZulu-Natal, South Africa | E-poster | D11 |
MOPED572 | The Kanyakla study: Randomized controlled trial of a microclinic social network intervention for promoting engagement and retention in HIV care in rural western Kenya | E-poster | D11 |
MOPED573 | Does intimate partner violence affect implementation of HIV services? A cross-sectional analysis of HIV-infected women in Coastal Kenya | E-poster | D11 |
MOPED574 | Cost-effectiveness of index HIV self-testing to reach male partners in Malawi | E-poster | D11 |
MOPED575 | Characteristics of sex workers who have never been tested for HIV: Analysis of bio behavioral data from Ukraine | E-poster | D11 |
MOPED576 | Acceptability of routinely offered paediatric HIV testing at paediatric outpatient clinics in an urban public hospital in Nairobi, Kenya | E-poster | D12 |
MOPED577 | University clinic HIV testing services versus external service providers' HIV testing services: A study of students' preferences for HIV testing services at 2 State Universities in Zimbabwe | E-poster | D12 |
MOPED578 | Persuaded HIV self-testing during community-based distribution of self-test kits: A population-based survey and nested qualitative study in Zimbabwe | E-poster | D12 |
MOPED579 | Barriers and innovative solutions to achieve the first “90” of HIV care cascade in Ukraine | E-poster | D12 |
MOPED580 | Facility optimization: Use of safe spaces to increase access to HIV testing services among MSM in Kisumu County, Kenya | E-poster | D12 |
MOPED581 | Routine HIV testing and suicide risk | E-poster | D12 |
MOPED582 | Comparison of potential effectiveness of universal testing versus index testing: Estimations from 4 years of data from the HPTN 071 (PopART) trial | E-poster | D12 |
MOPED583 | Utilisation patterns in male focused HIV testing services among rural men in KwaZulu-Natal, South Africa | E-poster | D12 |
MOPED584 | Utilization of HIV testing and counselling services (HTS) among female sex workers (FSWs) in a limited resource setting | E-poster | D12 |
MOPED585 | Rapid test for HIV at the point of care in Buenos Aires City: A strategy for prevention and health promotion outside of the institutional walls | E-poster | D12 |
MOPED586 | HIV self-testing in Zambia - an account of early lessons from multi-province program implementation scale-up | E-poster | D12 |
MOPED587 | Who self-reports never-testing for HIV after community-based distribution of HIV self-testing kits in Malawi, Zambia and Zimbabwe? | E-poster | D12 |
MOPED588 | LIGHT initiative phase 1: Integration of HIV testing in glandular fever serology ordersets - simple, effective and sustainable intervention to increase HIV testing in line with UK and European guidelines | E-poster | D12 |
MOPED589 | Uptake, knowledge, and quality of HIV testing and sexual and reproductive health services among adolescents enrolled in the girls achieve power trial: South Africa | E-poster | D12 |
MOPED590 | Too much of a good thing? Prevalence and determinants of frequent HIV testing in Zambia and Malawi | E-poster | D12 |
MOPED591 | Improving HIV testing and linkage to antiretroviral therapy among men through various male engagement strategies in Eswatini | E-poster | D12 |
MOPED592 | Partner notification as a strategy to achieve the first 90 in a high-prevalence county in Kenya | E-poster | D12 |
MOPED594 | Optimizing HIV fast-track strategy in rural communities in north-central Nigeria using prioritized community symptomatic testing (P-COST) model: Impact | E-poster | D12 |
MOPED595 | Traditional leaders are the game changers in attainment of 90-90-90 targets in the Sub-Saharan Africa | E-poster | D12 |
MOPED596 | Approaches to improving efficiency in HIV case finding: Results from the use of HIV risk assessment checklists in Kogi, North Central Nigeria | E-poster | D12 |
MOPED597 | The role of peer lay health worker programmes in supporting HIV re-testing among HIV-negative pregnant and breastfeeding women | E-poster | D12 |
MOPED598 | Primary prevention of HIV among HIV-negative pregnant and breastfeeding women | E-poster | D13 |
MOPED599 | First year of implementation of PrEP in Zambia: Service delivery roll-out and scale-up | E-poster | D13 |
MOPED600 | Challenges implementing pre-exposure prophylaxis (PrEP) for people who inject drugs in non-urban areas of the United States | E-poster | D13 |
MOPED601 | PrEPare for work: An intervention to increase PrEP uptake among male sex workers | E-poster | D13 |
MOPED602 | Assessing HIV care outcomes among African-born people living with HIV in Seattle: An analysis of the University of Washington Electronic Medical Record | E-poster | D13 |
MOPED603 | Navigating to scale: Results from a national programme for key populations in Kenya | E-poster | D13 |
MOPED604 | Awareness of PrEP and drivers and barriers to use among men aged 20-34 in Mpumalanga and KwaZulu-Natal, South Africa | E-poster | D13 |
MOPED605 | Impact and heterogeneous effects from behavioral economic incentives for improving antiretroviral (ARV) medication adherence in Uganda | E-poster | D14 |
MOPED606 | Mobile health technology, a revolution towards improving adherence to clinic appointment among PLHIV on antiretroviral therapy in Njombe and Morogoro regions in Tanzania | E-poster | D14 |
MOPED607 | A successful individualized communication strategy to enhance retention and ART uptake in naive individuals | E-poster | D14 |
MOPED608 | Evaluation of an Enhanced Adherence Counseling Model to achieve viral suppression among patients with initial virologic failure: A case study from South-Eastern Nigeria | E-poster | D14 |
MOPED609 | Integrating mobile phone interventions for adherence support in people living with HIV infection: Contextual difference affects the dynamics | E-poster | D14 |
MOPED610 | Depressive symptoms and ART adherence among caregivers of vulnerable children in Southern Malawi | E-poster | D14 |
MOPED611 | Peer navigation improves HIV care and viral suppression outcomes among South African men who have sex with men; results from a randomized controlled trail | E-poster | D14 |
MOPED612 | Patient feedback surveys about healthcare workers among women attending PMTCT services in eSwatini | E-poster | D15 |
MOPED613 | Reasons for defaulting and prolonging return to care in a cohort of pregnant women reinitiating HIV treatment under Option B+ | E-poster | D15 |
MOPED615 | Suboptimal engagement in HIV care among persons who inject drugs and their partners in Nairobi, Kenya | E-poster | D15 |
MOPED616 | Improved HIV treatment retention among patients enrolled in a differentiated care model at Kenya General Reference Hospital in Haut Katanga province of the Democratic Republic of the Congo | E-poster | D15 |
MOPED617 | Mortality and loss to follow-up among HIV positive adolescents and young adults in program settings in Kenya | E-poster | D15 |
MOPED618 | Characteristics of oral pre-exposure prophylaxis (PrEP) clients with periodic use in the Jilinde program, Kenya | E-poster | D15 |
MOPED619 | The role of peer lay health worker programmes in improving retention in HIV services | E-poster | D15 |
MOPED620 | Same day ART initiation: Retention into HIV care remains a challenge, a TASO Mbarara experience | E-poster | D15 |
MOPED621 | Is loss to follow up (LTFU) as defined by HIV treatment programs a true reflection of client retention in Northern Nigeria? | E-poster | D15 |
MOPED622 | Open access program to improve engagement in HIV treatment and care services at an urban community health center | E-poster | D15 |
MOPED623 | Differentiated service delivery using a “community pharmacy art drug pickup” model: An evaluation from Lusaka, Zambia | E-poster | D15 |
MOPED624 | Clinical outcomes of adolescents living with HIV after transitioning to adult care: A systematic review | E-poster | D15 |
MOPED625 | Lost to follow-up tracking drive - Mission ´SAMPARK´ in Gujarat | E-poster | D15 |
MOPED626 | Partner notification services optimize HIV case identification and linkage to treatment among key populations in Kenya | E-poster | D17 |
MOPED627 | Lottery incentives decrease time to ART initiation for South African men: Results from a randomized pilot study | E-poster | D17 |
MOPED628 | Use of mHealth to improve linkage to care outcomes and documentation in population based household SUrveys | E-poster | D17 |
MOPED629 | Human resources for health increases linkage between HIV testing and treatment in Zimbabwe | E-poster | D17 |
MOPED630 | Optimizing individual and public health benefits of assisted HIV self-testing through effective linkages to services for men who have sex with men and transgender women in Laos | E-poster | D17 |
MOPED631 | Calculating HIV reactivity rates amongst deferred blood donors at a tertiary hospital in Ghana to exemplify how health services limit progress towards 90-90-90 | E-poster | D17 |
MOPED632 | Alcoholic venue screening: A novel point of engagement with a hard-to-reach population of men for HIV testing and linkage to care in rural South Africa | E-poster | D17 |
MOPED633 | Early results from Test and Start implementation in Luanda, Angola | E-poster | D17 |
MOPED634 | Interventions to improve linkage to HIV care in the era of "Treat All" in sub-Saharan Africa: A systematic review | E-poster | D17 |
MOPED635 | Non-linkage to care after same-day ART initiation - reasons and acquisition of drug resistance: 24-month follow-up of non-linkers to care from the CASCADE trial in Lesotho | E-poster | D17 |
MOPED636 | Rapid initiation of ART through a Quality Improvement Collaborative in Zimbabwe | E-poster | D18 |
MOPED637 | Adam´s Love 7-Milestones positive journey map: A novel online-to-offline (O2O) HIV care strategy for early linkage to treatment and optimal retention in care among Thai HIV-positive MSM | E-poster | D18 |
MOPED638 | Patient satisfaction feedback (PSF) for ART services in Cambodia | E-poster | D18 |
MOPED639 | Feasibility and acceptability of a biometric mHealth system for monitoring retention in HIV services and delivering financial incentives to adults initiating antiretroviral therapy in Tanzania | E-poster | D19 |
MOPED640 | Viral suppression among HIV patients who receive SMS reminders for clinic appointments: Experience from USAID Boresha Afya program in Southern Tanzania | E-poster | D19 |
MOPED641 | Effectiveness of short message service (SMS) reminders on timely pick-up of antiretroviral therapy (ART) among consenting HIV-positive adults in Zambézia province, Mozambique | E-poster | D19 |
MOPED642 | Online and now within reach: Survey results for online populations at-risk for HIV in Cambodia | E-poster | D19 |
MOSY0105LB | Community-led delivery of HIV self-testing targeting adolescents and men in rural Malawi: a cluster-randomised trial | Oral abstract session with live Q&A | D8 |
PUB001 | National trends in TB/HIV comorbidity in Ukraine, 2008-2017 | Publication Only | B16 |
PUB002 | Scaling up peer driven intervention plus: An innovative approach to reach hidden MSM and TG in Cambodia | Publication Only | C47 |
PUB003 | Use of WhatsApp technology as a platform for improving Timeliness of data reporting in a hard-to-reach Rural Riverine Health facilities in South-South Nigeria | Publication Only | D42 |
PUB004 | Potential impact of implementing index partner notification to reach undiagnosed people living with HIV in Rwanda | Publication Only | D12 |
PUB005 | Provider-initiated HIV testing finds the majority of HIV positive persons in Kenya | Publication Only | C36 |
TUAA0101 | Two-year post-vaccination follow-up from APPROACH: Phase 1/2a randomized study evaluating safety and immunogenicity of prophylactic HIV vaccine regimens combining Ad26.Mos.HIV and gp140 envelope protein | Oral abstract session with live Q&A | A25 |
TUAA0102 | Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521Δ11mutC) and CD4-induced gp120 (rhFLSC) proteins | Oral abstract session with live Q&A | A40 |
TUAA0103 | A vaccine targeting HIV maturation protects Cynomolgus monkeys against vaginal SIVmac251 acquisition | Oral abstract session with live Q&A | A40 |
TUAA0104 | A helical structure in the V2 domain of gp120 that localizes to the site of immune pressure in the RV144 vaccine trial is conserved in HIV and SIV envelopes | Oral abstract session with live Q&A | A41 |
TUAA0105 | Lessons from the Research in Viral Eradication of Reservoirs (RIVER) study: Impact of a therapeutic vaccine targeting conserved HIV epitopes on T cell function in treated primary infection | Oral abstract session with live Q&A | A25 |
TUAA0201 | Preferential infection of α4β7+ CD4+ T cells in early acute HIV-1 infection | Oral abstract session with live Q&A | A34 |
TUAA0202 | Cellular proliferation maintains genetically intact and defective HIV-1 over time | Oral abstract session with live Q&A | A21 |
TUAA0203 | Adipose tissue contributes to viral persistence in ART-treated SIV.sab infection in pigtailed macaques | Oral abstract session with live Q&A | A21 |
TUAA0204 | Selective death induction of HIV-1 infected myeloid reservoirs | Oral abstract session with live Q&A | A23 |
TUAA0205LB | Contribution of naïve CD4+ T cells to the intact HIV reservoir | Oral abstract session with live Q&A | A21 |
TUAB0101 | Periconceptional antiretroviral exposure and central nervous system (CNS) and neural tube birth defects - data from Antiretroviral Pregnancy Registry (APR) | Oral abstract session with live Q&A | B58 |
TUAB0102 | Adverse pregnancy outcomes among HIV-positive women in the era of universal antiretroviral therapy (ART) remain elevated compared with HIV-negative women in Lesotho | Oral abstract session with live Q&A | B58 |
TUAB0103 | Vaginal inflammation is associated with initiating antiretroviral therapy in pregnancy and with spontaneous preterm birth | Oral abstract session with live Q&A | B58 |
TUAB0104 | Characterizing viral load burden among HIV-infected women at time of delivery: Findings from four tertiary obstetric units in Gauteng, South Africa | Oral abstract session with live Q&A | B58 |
TUAB0105 | Dual epidemics: The impact of HIV and obesity on pregnancy outcomes among women in South Africa | Oral abstract session with live Q&A | B58 |
TUAC0101 | Transgender people's experiences in HIV testing, sexual partner based violence and mental health in Malawi | Oral abstract session with live Q&A | C55 |
TUAC0102 | Acceptability of HIV and syphilis domiciliary testing among transgender women in Buenos Aires, Argentina | Oral abstract session with live Q&A | D84 |
TUAC0103 | Evaluation of syndemics in transgender women using pre-exposure prophylaxis (PrEP) for HIV prevention: Preliminary findings | Oral abstract session with live Q&A | D84 |
TUAC0104 | Regular consumption of alcohol and risk of HIV infection in transgender women in Fortaleza, Northeast Brazil | Oral abstract session with live Q&A | D84 |
TUAC0105 | Factors associated with current ART use among transwomen participating in TransAmigas study, São Paulo, Brazil | Oral abstract session with live Q&A | D84 |
TUAC0201 | Continuing low HIV incidence in the expanded pre-exposure prophylaxis (PrEP) implementation in communities - New South Wales study (EPIC-NSW) | Oral abstract session with live Q&A | C27 |
TUAC0202 | Incidence of HIV-infection with daily or on-demand PrEP with TDF/FTC in Paris area. Update from the ANRS Prevenir Study | Oral abstract session with live Q&A | C27 |
TUAC0203 | High adherence and sustained impact on HIV-1 incidence: Final results of an open-label extension trial of the dapivirine vaginal ring | Oral abstract session with live Q&A | C28 |
TUAC0204 | What is the effect of layered prevention interventions on HIV risk among adolescent girls in Zambia? | Oral abstract session with live Q&A | C57 |
TUAC0205LB | Sitakhela Likusasa Impact Evaluation: results of a cluster randomized control trial (cRCT) of financial incentives for HIV prevention among adolescent girls and young women (AGYW) in Eswatini | Oral abstract session with live Q&A | C57 |
TUAC0301 | PrEP adherence and effect of drug level feedback among young African women in HPTN 082 | Oral abstract session with live Q&A | C27 |
TUAC0302 | PrEP uptake and early adherence among at HIV risk transgender women from Rio de Janeiro, Brazil: Results from the PrEParadas study | Oral abstract session with live Q&A | C55 |
TUAC0303 | Factors associated with stopping HIV pre-exposure prophylaxis (PrEP) for three months or more in the EPIC-NSW trial | Oral abstract session with live Q&A | C27 |
TUAC0304 | PrEP re-initiation after interruption by adolescent girls and young women in Kenya and South Africa | Oral abstract session with live Q&A | C27 |
TUAC0305LB | Frequent detection of tenofovir-diphosphate among young Kenyan women in a real-world PrEP implementation program | Oral abstract session with live Q&A | C39 |
TUAC0305LB | Frequent detection of tenofovir-diphosphate among young Kenyan women in a real-world PrEP implementation program | Oral abstract session with live Q&A | C39 |
TUAC0401LB | First-in-human trial of MK-8591-eluting implants demonstrates concentrations suitable for HIV prophylaxis for at least one year | Oral abstract session with live Q&A | C32 |
TUAC0402LB | ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26.Mos4.HIV and either clade C gp140 or bivalent gp140 | Oral abstract session with live Q&A | C30 |
TUAC0403LB | DISCOVER study for HIV pre-exposure prophylaxis (PrEP): F/TAF has a more rapid onset and longer sustained duration of HIV protection compared with F/TDF | Oral abstract session with live Q&A | C27 |
TUAC0404LB | Safety, early continuation and adherence of same day PrEP initiation among MSM and TGW in Brazil, Mexico and Peru: the ImPrEP Study | Oral abstract session with live Q&A | C27 |
TUAD0101 | How do HIV cure trial researchers respond to an embedded social science study? | Oral abstract session with live Q&A | D43 |
TUAD0102 | Bringing good participatory practice into action: Considerations and challenges from a sponsor perspective | Oral abstract session with live Q&A | D101 |
TUAD0103 | Getting from good participatory practice to good trial outcomes for everyone: How stakeholders believe GPP works (or not) | Oral abstract session with live Q&A | D56 |
TUAD0104 | The game-changing nature of early and ongoing community engagement in HIV prevention efficacy trials: The AMP studies' experience (HVTN 703/HPTN 081 & HVTN 704/HPTN 085) | Oral abstract session with live Q&A | D56 |
TUAD0106 | Engaging youth as long-acting HIV prevention product co-researchers in the iPrevent study in Cape Town, South Africa | Oral abstract session with live Q&A | D56 |
TUAD0201 | Modelling combination interventions including increased school attendance to prevent HIV among girls of school age in South Africa (HPTN 068) | Oral abstract session with live Q&A | D99 |
TUAD0202 | Improving uptake of prevention of mother-to-child HIV transmission services in Benue State, Nigeria through a church congregation-based approach | Oral abstract session with live Q&A | D6 |
TUAD0203 | Does early infant male circumcision increase mothers' attendance for postnatal care services? Findings from Iringa and Njombe Regions, Tanzania | Oral abstract session with live Q&A | D94 |
TUAD0204 | Condom and oral PrEP use among female sex workers: Findings from a study in South Africa | Oral abstract session with live Q&A | D99 |
TUAD0205 | Improving prevention choice while we wait for an HIV vaccine: Prioritizing resources for key population-specific prevention research and implementation | Oral abstract session with live Q&A | D36 |
TUAD0301 | Do changes in development assistance for health crowd out domestic investment for health and what are the implications for HIV/AIDS outcomes | Oral abstract session with live Q&A | D36 |
TUAD0302 | From “nice-to-have” to “necessary”: Increases in domestic financing and perceived value of key population-lead HIV services by the Thai government as international donor funding transitions | Oral abstract session with live Q&A | D35 |
TUAD0303 | Study comparative NASA and budget tracking: Enabling and empowering the local budget and resource allocation in Bandung district | Oral abstract session with live Q&A | D40 |
TUAD0304 | Exploring the unit cost variation of Mexico's HIV treatment program: A facility-level longitudinal analysis | Oral abstract session with live Q&A | D48 |
TUAD0305LB | Achieving low antiretroviral (ARV) costs through competitive national tendering and strategic reference pricing: Results from the Republic of South Africa's recently awarded ARV tender (RT71-2019) | Oral abstract session with live Q&A | D39 |
TUPDA0101 | Maternal HIV infection alters the community composition and dynamics of the enteric microbiome of associated infants | Poster exhibition | A12 |
TUPDA0102 | Glycomic determinants of gut microbial dysbiosis and translocation during suppressed HIV infection | Poster exhibition | A12 |
TUPDA0103 | Relevance of Reg3α and I-FABP on microbial translocation, inflammation and reservoir size in people living with HIV | Poster exhibition | A12 |
TUPDA0104 | HIV acquisition risk and genital inflammation associated with hormonal contraceptives is dependent on the vaginal microbiome | Poster exhibition | A30 |
TUPDA0105 | Recent injectable contraception correlates with reduced cervicovaginal mucosal growth factor expression in South African women | Poster exhibition | A9 |
TUPDA0106 | The effect of hepatitis C (HCV) cure on markers of macrophage activation and microbial translocation among HIV seropositive women | Poster exhibition | B18 |
TUPDA0107LB | Contraceptive-induced changes in genital tract HIV-1 cellular targets and microbiota among women enrolled in the ECHO Trial | Poster exhibition | A30 |
TUPDB0101 | Apples and oranges: Assessment of the care cascade in sub-Saharan Africa | Poster exhibition | B11 |
TUPDB0102 | Gaps in the continuum of care. Loss to follow-up and return to care: Who is at risk? | Poster exhibition | B46 |
TUPDB0103 | Understanding gaps in the HIV treatment cascade in 11 West African countries: Findings from the regional Community Treatment Observatory | Poster exhibition | B11 |
TUPDB0104 | The “Failure Cascade” for patients with unsuppressed viral load in Zambia: Results from a large HIV treatment cohort | Poster exhibition | B46 |
TUPDB0105 | The hepatitis C treatment cascade in the era of direct-acting antivirals (DAAs), and barriers to DAA treatment initiation, among US men and women with and without HIV | Poster exhibition | B18 |
TUPDB0106 | Actively contributing to a cascade of change: Analysis of the TB treatment cascade among children and adolescents living with HIV in six high TB/HIV burden countries | Poster exhibition | B70 |
TUPDC0101 | Measuring perceptions of sexual risk among adolescent girls and young women taking PrEP: A new qualitative method using visual timelines in HPTN 082 | Poster exhibition | D54 |
TUPDC0102 | High uptake and adherence to periconception PrEP among women in South Africa | Poster exhibition | C42 |
TUPDC0103 | Safer conception services: A model to support progress towards 90-90-90 goals for men and women with horizontal and vertical HIV transmission risks | Poster exhibition | C42 |
TUPDC0104 | Prevalence of HIV and other sexually transmitted infections among female sex workers in Moscow, Russia: Results from a community-based, cross-sectional study using respondent driven sampling methodology | Poster exhibition | C6 |
TUPDC0105 | PrEP use and sexually transmitted infections are not associated longitudinally in a cohort study of young men who have sex with men in Chicago | Poster exhibition | C27 |
TUPDC0106 | Prospective, multicenter study to assess point prevalence, incidence and recurrence of sexually transmitted infections in men who have sex with men in Germany: BRAHMS study | Poster exhibition | C35 |
TUPDD0101 | Measuring anticipated sex-work stigma: Scale validation and association with HIV and non-HIV service utilization | Poster exhibition | D83 |
TUPDD0102 | Mapping key population hotspots in Nigeria for targeted HIV program planning | Poster exhibition | D4 |
TUPDD0103 | The M-Spot 2 Study: Feasibility of measuring viral load longitudinally using home-collected dried blood spot specimens of high-risk MSM living with HIV | Poster exhibition | D9 |
TUPDD0104 | Developing and validating a model for risk-based differentiation of HIV prevention and testing services for female sex workers: Experiences from Maharashtra, India | Poster exhibition | D98 |
TUPDD0105 | Receipt of medication-assisted treatment halves the risk of HIV-1 RNA viral load rebound for HIV-positive women who use illicit drugs | Poster exhibition | D82 |
TUPDD0106 | Police harassment and alcohol and drug abuse is associated with poorer 6-month retention among transgender women starting ART in a clinical trial in Argentina | Poster exhibition | D84 |
TUPDD0201 | Exploring the mediating role of tobacco use in the relationship between intersectional stigma and HIV clinical outcomes among women living with HIV in Canada | Poster exhibition | D70 |
TUPDD0202 | Implementation of social capital theory and process to strengthen state-level combination prevention outcomes in 12 states in Mexico | Poster exhibition | D51 |
TUPDD0203 | Frustrated patients, frustrated providers: A comprehensive integrated conceptual model to explain why patients delay, decline, or discontinue HIV medication and strategies to boost sustained HIV viral suppression in populations at-risk | Poster exhibition | D53 |
TUPDD0204 | Estimating plausible ranges on the scale of implementation for evidence-based HIV/AIDS interventions in the US | Poster exhibition | D48 |
TUPDD0205 | Extrapolation of population size estimates for key populations: Impact of method of extrapolation on estimates produced using regional estimates of female sex workers from Tanzania as an illustrative example | Poster exhibition | D1 |
TUPDD0206LB | Quantifying the contribution of different aged men and women to onwards transmission of HIV-1 in generalised epidemics in sub-Saharan Africa: A modelling and phylogenetics approach from the HPTN071 (PopART) trial | Poster exhibition | D53 |
TUPEA001 | Genetic characterization HIV-1 sequences from Cabo Verde points to a new sub-subtype A | E-poster | A1 |
TUPEA002 | Identification of two new HIV-1 BF intersubtype circulating recombinant forms of South American origin, CRF66_BF and CRF75_BF, which also circulate in Southern Europe | E-poster | A1 |
TUPEA003 | Near full-length genome sequences of recombinant HIV-1 viruses derived from parental strains expanding in transmission clusters in Spain | E-poster | A1 |
TUPEA004 | Acquired drug resistance surveillance in HIV-1 treated patients in Senegal | E-poster | A2 |
TUPEA005 | Impact of CCR2 genetic polymorphisms in HIV acquisition in a Northern Cameroonian pediatric population | E-poster | A3 |
TUPEA006 | Upregulation of DNA methylation-dependent repressors ZBTB4 and ZBTB38 in CD4+ T cells from HIV+ patients | E-poster | A5 |
TUPEA034 | The replication-competent HIV reservoir is detectable in circulating monocytes and is increased in ART-suppressed chronic HIV-infected individuals with neurocognitive impairment | E-poster | A15 |
TUPEA035 | Impact of suppressive cART on reduction of inflammation in the CNS of Chinese-origin rhesus macaques with SIV infection | E-poster | A15 |
TUPEA072 | Heterogeneity of HIV co-receptor expression on CD4+ T cell subsets in human rectal mucosal tissues | E-poster | A30 |
TUPEA074 | Triterpene derivative NAT-078 as a novel bifunctional HIV-1 entry inhibitor | E-poster | A35 |
TUPEA075 | In vitro resistance profile of GS-6207, a first-in-class picomolar HIV capsid inhibitor in clinical development as a novel long-acting antiretroviral agent | E-poster | A35 |
TUPEA076 | Development of a pleuricellular ex-vivo foreskin model of HIV infection | E-poster | A35 |
TUPEA077 | Synergistic inhibition of cell-to-cell infection of HIV-1 by the combination of single chain fragment variables (scFvs) and fusion inhibitors | E-poster | A35 |
TUPEA078 | Effect of human milk sulfated glycosaminoglycans on HIV-1 infection of human CD4+ cells in vitro | E-poster | A35 |
TUPEA096 | Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda | E-poster | A50 |
TUPEA097 | Bioinformatic analyses followed by phenotypic assays detect two new mutations associated with patients failing Raltegravir in Uganda | E-poster | A50 |
TUPEA098 | Accuracy, sensitivity, and specificity of the cobas® Plasma Separation Card on cobas® 8800 System vs DBS on Abbott m2000 for the classification of HIV virological failure as compared to plasma | E-poster | A50 |
TUPEA099 | Field evaluation of HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Nigeria by dried blood spot testing with realtime HIV-1 on m2000 | E-poster | A50 |
TUPEA102 | Tenofovir alafenamide-releasing nanochannel drug delivery system for PrEP | E-poster | A53 |
TUPEA103 | Forgiveness of antiretroviral regimens: In vitro HIV-1 viral breakthrough with 2-drug versus 3-drug regimens simulating variable adherence to treatment | E-poster | A53 |
TUPEA104 | Abacavir sulphate increases vascular endothelial activation and endothelial-platelet crosstalk: Mechanisms of cardiovascular risk? | E-poster | A53 |
TUPEA105 | OB-002 (5P12-RANTES) is significantly more potent than other CCR5 antagonists in development for the treatment or prevention of HIV infection | E-poster | A53 |
TUPEA106 | Sustained release of cabotegravir from nanochannel delivery implant for HIV PrEP | E-poster | A53 |
TUPEA107 | Association between Integrase Strand Transfer Inhibitors and serummagnesium levels | E-poster | A55 |
TUPEA108 | Functional expression of antiretroviral drug efflux transporters and metabolic enzymes in human peripheral and testicular T cell subsets | E-poster | A55 |
TUPEA109 | Drug efflux transporters and metabolic enzymes in circulating myeloid cells of HIV-infected individuals | E-poster | A55 |
TUPEA110 | The role of Raltegravir alone or combined with lamivudine as PrEP: A Phase 2 randomised controlled clinical trial | E-poster | A55 |
TUPEA111 | Targeting lopinavir to gut-associated lymphoid tissue by lipophilic prodrug approach for improved treatment of HIV/AIDS | E-poster | A55 |
TUPEB142 | Evaluation of a computerized neuropsychological test battery for diagnosing HIV-associated neurocognitive disorders (HAND) | E-poster | B13 |
TUPEB143 | Performance evaluation of automated real-time PCR assays for diagnosis of TB in HIV infected individuals | E-poster | B13 |
TUPEB144 | Pulmonary arterial hypertension in HIV positive patients in a low income country | E-poster | B13 |
TUPEB145 | Point-of-care cryptococcal antigen screening predicts cryptococcal meningitis and mortality among people living with HIV in a South African Township | E-poster | B13 |
TUPEB146 | Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda | E-poster | B13 |
TUPEB147 | Diagnostic performance of Xpert MTB/RIF for pulmonary tuberculosis screening in AIDS-associated Kaposi sarcoma in Zimbabwe | E-poster | B13 |
TUPEB150 | Kaposi´s Sarcoma Herpesvirus (KSHV) in Cuba: Prevalence and molecular epidemiology | E-poster | B15 |
TUPEB151 | The changing epidemiology of HIV-associated adult meningitis, Uganda 2015 - 2017 | E-poster | B15 |
TUPEB152 | CD4 count-based guidelines for tuberculin skin testing and tuberculosis preventive therapy in people living with HIV | E-poster | B16 |
TUPEB153 | Changes of NK cell repertoire related to the onset of immune reconstitution inflammatory syndrome In TB/HIV co-infection | E-poster | B16 |
TUPEB154 | Impact of late presentation and late ART initiation on TB incidence across four countries | E-poster | B16 |
TUPEB155 | Incidence and predictors of active tuberculosis among HIV-infected adults receiving long term antiretroviral therapy in Thailand | E-poster | B16 |
TUPEB156 | Diagnostic features of tuberculosis peritonitis in HIV-positive patients | E-poster | B16 |
TUPEB157 | High programmatic isoniazid preventive therapy (IPT) use in pregnant HIV-infected women including periconception and early pregnancy initiation | E-poster | B16 |
TUPEB158 | ART initiation within 8 weeks of TB treatment Leads to superior TB outcomes in ART-naïve children and adolescents living with HIV: Results from six high TB/HIV burden countries | E-poster | B16 |
TUPEB159 | Evaluation of the World Health Organization (WHO) 4 symptom screening for intensified Tuberculosis (TB) case finding among people living with HIV (PLHIV) in India | E-poster | B16 |
TUPEB161 | Identification of biomarkers to predict disease progression at time of TB diagnosis | E-poster | B16 |
TUPEB162 | Treatment outcomes of HIV-TB co-infected children below 18 years of age: A cohort study | E-poster | B16 |
TUPEB163 | Severe adherence challenges in the treatment of multi- and extensively drug resistant tuberculosis and HIV: Electronic dose monitoring and mixed methods to identify and characterize high-risk subpopulations | E-poster | B16 |
TUPEB164 | Examining isoniazid concentrations in hair as a novel metric of adherence among HIV/TB co-infected persons receiving TB prophylaxis in Uganda | E-poster | B16 |
TUPEB165 | Prevalence of latent tuberculosis infection in HIV-infected patients using tuberculin skin test and Interferon-Gamma Release Assay | E-poster | B16 |
TUPEB166 | Characteristics and risk of mortality among TB/HIV co-infected patients at a large HIV clinic in the era of test and treat in Uganda | E-poster | B16 |
TUPEB167 | In silico prediction of major histocompatibility complex (MHC) class II epitopes associated with hepatitis B virus (HBV) infection in Botswana | E-poster | B17 |
TUPEB168 | Cell-associated HIV DNA levels in peripheral blood similar among hepatitis B and C virus coinfected and HIV mono-infected Chinese patients | E-poster | B17 |
TUPEB169 | Continued virological benefits but stabilised HBsAg loss after 8 years of tenofovir-inclusive ART regimens in HIV-HBV co-infection | E-poster | B17 |
TUPEB170 | Inflammatory markers associated with mortality in HIV-positive individuals from Côte d'Ivoire: Role of HIV-HBV co-infection | E-poster | B17 |
TUPEB171 | An investigation of the mechanisms and changes in chronic immune activation in patients with HIV/HBV co-infection after receiving HAART | E-poster | B17 |
TUPEB172 | Effectiveness of generic direct-acting agents to HCV treatment: A systematic review and meta-analysis | E-poster | B18 |
TUPEB173 | Incidence of hepatitis C virus infection among HIV-positive men in Singapore: Trends and epidemiological risk factors | E-poster | B18 |
TUPEB174 | Use of the HCV-MOSAIC risk score for identification of hepatitis C virus (HCV) reinfection in HIV-infected men who have sex with men (MSM) | E-poster | B18 |
TUPEB175 | Self-reported risk factors to better predict HCV infection in general population | E-poster | B18 |
TUPEB176 | Hepatitis C virus co-infection and the risk of peripheral artery disease among HIV-infected patients: Population-based study | E-poster | B18 |
TUPEB177 | Characteristics of patients diagnosed with hepatitis C across different care settings: Implications for improving diagnosis and linkage to care | E-poster | B18 |
TUPEB178 | Association between tenofovir disoproxil fumarate exposure and reduced bone mineral density in a cohort of HIV-positive patients: Results from 21 years of follow-up | E-poster | B18 |
TUPEB179 | Treatment outcome of simplified HCV testing and generic sofosbuvir/velpatasvir in Myanmar (USAID/EQUIP project) | E-poster | B18 |
TUPEB180 | Correlates of unsuccessful HCV therapy: HIV co-infected vs. HCV mono-infected people who use drug (PWUD) | E-poster | B18 |
TUPEB181 | Predictors of decreasing bone mineral density after switching from TDF to TAF in Japanese subjects with HIV | E-poster | B18 |
TUPEB182 | High risk human papillomavirus oral infection in people with HIV/AIDS, before and after combined antiretroviral therapy initiation | E-poster | B21 |
TUPEB183 | Incidence rate of high-grade anal squamous Intraepithelial Neoplasia (HG-AIN) among HIV-infected and high risk men who have sex with men (MSM) in resource-limited settings | E-poster | B21 |
TUPEB184 | Genotypic diversity of anal HPV amongst HIV-infected women reporting for routine cervical cancer screening in Harare, Zimbabwe | E-poster | B21 |
TUPEB185 | Factors associated with sexually transmitted infections among HIV-positive clients in same-day antiretroviral therapy cohort in Bangkok, Thailand | E-poster | B22 |
TUPEB186 | Clinical prediction of neurosyphilis in HIV-infected patients with early syphilis | E-poster | B22 |
TUPEB187 | Quick Sequential Organ Failure Assessment score predicts mortality among hospitalized patients with HIV/AIDS | E-poster | B23 |
TUPEB188 | Schistosomiasis is not a strong risk factor for HIV acquisition in four prospective cohorts: A nested case-control analysis | E-poster | B23 |
TUPEB189 | Cross-talk between H.pylori and gastric microbiome among people living with HIV | E-poster | B23 |
TUPEB190 | Bloodstream infection (BSI) in HIV-infected and HIV-uninfected patients in a tertiary hospital in Barcelona, Spain: A 16-year comparative study | E-poster | B23 |
TUPEB191 | Shorter CD8 T cell subset telomeres and lower proliferative: Senescent CD8 ratio in people with chronic/latent viral coinfections | E-poster | B23 |
TUPEB192 | Parkinson's disease diagnoses in a population-based cohort of people living with HIV and a comparative general population sample in British Columbia, Canada | E-poster | B24 |
TUPEB193 | CSF viral escape among HIV-infected patients in Southern India | E-poster | B24 |
TUPEB194 | Co-morbidity of HIV and psychosis among the In-patients at the national tertiary psychiatric hospital in Malawi | E-poster | B25 |
TUPEB195 | Role of immune suppression as independent prognostic factor of NHL outcome in PLWHIV | E-poster | B26 |
TUPEB196 | Malignancies' standardized incidence rates among adults' Hispanic people living with HIV in the recent cART era, Puerto Rico 2010-2015 | E-poster | B26 |
TUPEB197 | First report on salivary shedding, viremia and seroprevalence of Kaposi´s sarcoma associated herpes virus among a group of men who have sex with men and transgender women from Argentina | E-poster | B26 |
TUPEB198 | Improving access to cervical cancer screening services at remote areas in Tanzania | E-poster | B26 |
TUPEB199 | Head and neck cancers in U.S. Veterans living with HIV | E-poster | B26 |
TUPEB200 | Gut microbial dysbiosis in HIV-infected males with different sexual behaviour and cardiovascular risk | E-poster | B27 |
TUPEB201 | Cardiovascular disease risk among HIV-infected and uninfected adults in Kisumu, Kenya | E-poster | B27 |
TUPEB202 | Framingham, EURO and asCVD risk scores perform less good in HIV+ individuals from the HIVH-study compared to the general population | E-poster | B27 |
TUPEB203 | Impact of HIV specific and traditional risk factors on the incidence of cardiovascular events in HIV-positive males over time | E-poster | B27 |
TUPEB204 | Longitudinal analysis of blood pressure and estimation of the effect of HIV on BP mediated through HIV-specific pathways in a mixed cohort in Uganda | E-poster | B27 |
TUPEB206 | Estimated glomerular filtration rate (eGFR) Slopes on Tenofovir Alafenamide (ESTA) | E-poster | B29 |
TUPEB207 | Renal function with dolutegravir, elvitegravir/cobicistat, raltegravir, or darunavir | E-poster | B29 |
TUPEB208 | Outcome of early-switching of Tenofovir Disoproxil Fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: A prospective study | E-poster | B29 |
TUPEB209 | Real-world eGFR change among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent class | E-poster | B29 |
TUPEB210 | Prevalence and associated risk factors for diabetes at HIV diagnosis in South Africa | E-poster | B30 |
TUPEB211 | Switch from tenofovir to raltegravir is not associated with weight gain over 96 weeks | E-poster | B30 |
TUPEB212 | HIV+ women with diabetes mellitus exhibit CD4+ T lymphocyte immunometabolic dysfunction | E-poster | B30 |
TUPEB213 | Abnormal liver function tests are common during acute HIV infection, correlate with HIV viral load, and do not persist in individuals initiating antiretroviral therapy | E-poster | B31 |
TUPEB214 | The physical and mental health implications of vision impairment in aging HIV-infected men | E-poster | B32 |
TUPEB215 | Low muscle mass is the body composition parameter most predictive of pre-frailty and frailty in Asians living with HIV | E-poster | B32 |
TUPEB216 | Characterizing Canadians living with HIV to improve management of comorbidities | E-poster | B32 |
TUPEB217 | Smoking and High HIV viremia damage mitochondrial DNA and may accelerate mtDNA aging | E-poster | B32 |
TUPEB218 | Depression is associated with greater telomere attrition over time in HIV-infected women- implications to aging in long living women with HIV infection | E-poster | B32 |
TUPEB219 | Dolutegravir is associated with Kaposi Sarcoma's Immune Reconstitution Inflammatory syndrome in a cohort of AIDS patients in Rio de Janeiro, Brazil | E-poster | B33 |
TUPEB220 | Elevated anti-CMV IgG titer is associated with microbial translocation in elite controllers and ART-treated people living with HIV | E-poster | B33 |
TUPEB221 | Gastrointestinal disorders following initiation of dolutegravir, elvitegravir, raltegravir or darunavir | E-poster | B35 |
TUPEB222 | Prevalence and outcomes for heavily treatment-experienced (HTE) individuals living with HIV in a European Cohort | E-poster | B35 |
TUPEB303 | Long-term growth among children stunted at ART initiation in Malawi | E-poster | B70 |
TUPEB309 | High prevalence of anal and oral high risk-human papillomavirus in HIV-negative French men who have sex with men taking pre-exposure prophylaxis | E-poster | B76 |
TUPEC381 | Development of a scale to assess male partner involvement in the prevention of mother-to-child transmission of HIV | E-poster | C24 |
TUPEC382 | Reasons for exclusion from voluntary medical male circumcision: Project IQ Malawi experience | E-poster | C25 |
TUPEC383 | Maximizing voluntary medical male circumcision for HIV prevention in Lilongwe, Malawi, by targeting men in priority age group (15-29 years) | E-poster | C25 |
TUPEC384 | Modeling the impact of Voluntary Medical Male Circumcision (VMMC) on cervical cancer in Uganda | E-poster | C25 |
TUPEC385 | Post-exposure prophylaxis in victims of sexual violence. 10 years' experience at the Condesa Specialized Clinic (CSC) | E-poster | C26 |
TUPEC386 | Eighteen years experience of prophylaxis after sexual exposure to HIV (PEP): Comparison between two decades | E-poster | C26 |
TUPEC387 | Zero: The seroconversion rate of Mozambican health workers occupationally exposed to HIV | E-poster | C26 |
TUPEC388 | Use of HIV postexposure prophylaxis after sexual assault among female sex workers in Brazil | E-poster | C26 |
TUPEC389 | Awareness of HIV Postexposure Prophylaxis among female sex workers in Brazil | E-poster | C26 |
TUPEC390 | Projected impact of concurrent availability of long-acting injectable and daily-oral PrEP among men who have sex with men | E-poster | C27 |
TUPEC391 | PrEP users perceive high community-level PrEP stigma in Kenya | E-poster | C27 |
TUPEC392 | Level of polysubstance use is associated with increased sexually transmitted infections but not with decreased PrEP adherence in MSM | E-poster | C27 |
TUPEC393 | A pooled analysis of the effect of adherence on the renal safety of FTC/TDF (Truvada) for PrEP: 7 international demonstration projects | E-poster | C27 |
TUPEC394 | Temporal dynamics of sexual behaviour among MSM on sequential daily and event-driven PrEP: Results from a crossover study | E-poster | C27 |
TUPEC395 | Factors associated with increased condomless sex in a PrEP adherence trial: Possible clues into who is most at risk | E-poster | C27 |
TUPEC396 | Pre-exposure prophylaxis and STIs screenings in the Dominican Republic: Is an integrated approach necessary to scale-up? | E-poster | C27 |
TUPEC397 | Indications for PrEP and engagement along the PrEP continuum among emerging adult men who have sex with men in the Mid-Atlantic United States | E-poster | C27 |
TUPEC399 | Awareness and willingness to use PrEP among female sex workers in Dar-es-Salaam | E-poster | C27 |
TUPEC400 | Latent class analysis of current use and willingness of adopting pre-exposure prophylaxis in men who have sex with men in Taiwan: Subgroup analysis from 2017 Hornet/HEART Survey | E-poster | C27 |
TUPEC401 | Homelessness at diagnosis is the strongest predictor of death among persons with HIV in a population-based study of a U.S. city | E-poster | C27 |
TUPEC402 | PrEP knowledge and attitudes among adults attending public health clinics in Southern Arizona | E-poster | C27 |
TUPEC403 | Differences in adherence to TDF/FTC for PrEP in community health centers in the US: Medication Adherence Sub-study (MAS) of the Sustainable Health Center Implementation PrEP Pilot (SHIPP) | E-poster | C27 |
TUPEC404 | Can we believe the patient's estimates? A comparison between measured treatment adherence and patient-estimated treatment adherence by patients enrolled in a PrEP pilot study in the Dominican Republic | E-poster | C27 |
TUPEC405 | Utilization of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) for HIV pre-exposure prophylaxis (PrEP) in the United States by age, gender and ethnicity (2014 - 2017) | E-poster | C27 |
TUPEC406 | Factors affecting adherence to HIV pre-exposure prophylaxis (PrEP) among female sex workers taking PrEP in Kampala, Uganda | E-poster | C27 |
TUPEC407 | Use of HIV pre-exposure prophylaxis reduces HIV anxiety among high risk gay and bisexual men | E-poster | C27 |
TUPEC408 | Baseline and early follow up in the My PrEP study: A pilot PrEP demonstration project in high risk men who have sex with men (MSM) in Kuala Lumpur, Malaysia | E-poster | C27 |
TUPEC409 | Key population-delivered oral pre-exposure prophylaxis: Initial enrollment, adherence and retention results among men who have sex with men in Vietnam | E-poster | C27 |
TUPEC410 | Precedent factors in association with using PrEP event-driven over daily dosing regimen among men who have sex with men in Taiwan: A mixed-effect model analysis | E-poster | C27 |
TUPEC411 | Condomless anal intercourse and adequacy of protection from HIV pre-exposure prophylaxis (PrEP) in the EPIC-NSW trial | E-poster | C27 |
TUPEC412 | Preliminary findings on pre-exposure prophylaxis uptake and continuation among female sex workers and men who have sex with men in Thika, Kenya | E-poster | C27 |
TUPEC413 | Modeling parallel reductions in anxiety and HIV worry among PrEP users: Evidence for mental health benefits of PrEP implementation | E-poster | C27 |
TUPEC414 | PrEP awareness and potential/actual use among MSM at risk for HIV infection in the Latin American MSM Internet Survey (LAMIS) | E-poster | C27 |
TUPEC415 | Factors associated with PrEP Use and willingness to use PrEP among MSM at risk for HIV infection in the Latin American MSM Internet Survey (LAMIS) | E-poster | C27 |
TUPEC416 | Challenges and barriers to PrEP implementation in public health facilities in Latin America: Initial lessons from the ImPrEP demonstration project in Peru | E-poster | C27 |
TUPEC417 | The awareness of and willingness to use pre-exposure prophylaxis among men who have sex with men in China | E-poster | C27 |
TUPEC418 | TDF/FTC pre-exposure prophylaxis (PrEP) from 2012 to 2018 in the OPERA cohort | E-poster | C27 |
TUPEC419 | Pre-exposure prophylaxis (PrEP) in Spain: 24-week results after of the feasibility study for PrEP implementation | E-poster | C27 |
TUPEC420 | Service provider insights: Implications for national training and support for PrEP provision in South Africa | E-Poster BU Poster exhibition | C27 |
TUPEC421 | PrEP use among MSM in Brazil: First results from Latin America MSM Internet Survey (LAMIS) | E-poster | C27 |
TUPEC422 | Awareness and willingness to use PrEP among men who have sex with men in Mexico, Encuesta de Sexo Entre Hombres, 2017 | E-poster | C27 |
TUPEC423 | Health care providers' self-efficacy at providing oral pre-exposure prophylaxis (PrEP) in Kenya: Results from a cross-sectional survey | E-Poster BU Poster exhibition | C27 |
TUPEC424 | Longitudinal analysis of renal function among participants in a large Australian PrEP demonstration study, PrEPX | E-poster | C27 |
TUPEC425 | Model-based comparison of the individual-level and community-level benefits of PrEP in South Africa: Implications for priority populations | E-poster | C27 |
TUPEC426 | “I always use condoms - with that one” - different risk compensation dynamics in different population groups: Evidence from a qualitative study of PrEP clients in Eswatini | E-poster | C27 |
TUPEC427 | Longitudinal changes in condom use with casual partners among gay and bisexual men using HIV pre-exposure prophylaxis | E-poster | C27 |
TUPEC428 | HIV infection after stopping PrEP in a U.S. safety-net integrated health system: A mixed methods study | E-poster | C27 |
TUPEC429 | The global PrEP research landscape: Mapping studies of oral PrEP implementation and impact | E-poster | C27 |
TUPEC430 | Initiation and persistence of oral pre-exposure prophylaxis (PrEP) by adolescent girls and young women (AGYW) for HIV prevention in Kenya | E-poster | C27 |
TUPEC431 | Tracking oral PrEP access globally: Using initiation trend data to inform product introduction | E-poster | C27 |
TUPEC432 | Change in awareness of, willingness to and utilization of PrEP over the past two years in Japan | E-poster | C27 |
TUPEC433 | PrEP as a potential solution in Yangon, Myanmar to address high behavioral risk for HIV acquisition among men who have sex with men and transgender women: A mixed-methods assessment | E-poster | C27 |
TUPEC434 | Short-term adherence marker to PrEP is strongly associated with future discontinuation in a large PrEP Demo Project in the U.S: Implications for point-of-care urine adherence testing | E-poster | C27 |
TUPEC435 | Barriers to and facilitators of PrEP uptake: Lessons from FHI 360/Ministry of Health demonstration Project in the Kingdom of Eswatini | E-poster | C27 |
TUPEC436 | Longer term PrEP users in a Boston community health center: Sociodemographic factors and PrEP persistence | E-poster | C27 |
TUPEC437 | Barriers and facilitators of PrEP use: A synthesis of proceedings of the Empowering Women´s Health Summit, Miami, FL, 2018 | E-poster | C27 |
TUPEC438 | PrEP uptake, engagement, and adherence following population-wide HIV testing in rural Kenya and Uganda in the SEARCH study | E-poster | C27 |
TUPEC439 | Identifying and addressing barriers to pre-exposure prophylaxis initiation via telecommunication intervention in urban NYC | E-poster | C27 |
TUPEC440 | Determinants of PrEP uptake in the general population in Eswatini | E-poster | C27 |
TUPEC441 | Mapping the need and benefit of PrEP in three African countries to estimate programmatic targets | E-poster | C27 |
TUPEC442 | Leveraging mobile health to promote uptake, retention and success of elimination of mother to child transmission of HIV (EMTCT) in Uganda, 2016 -2017 | E-poster | C29 |
TUPEC443 | Awareness, preferences, and willingness to pay for HIV self-tests in Kenya | E-poster | C33 |
TUPEC444 | Immune biomarkers are associated with HIV exposure or infection in children using DBS | E-poster | C33 |
TUPEC445 | Factors associated with acceptability of HIV self-testing among men who have sex with men in 12 Brazilian cities | E-poster | C33 |
TUPEC446 | Stakeholders perceptions towards implementing HIV self-testing as an assisted partner services strategy to reach men in Haiti | E-poster | C33 |
TUPEC447 | Uptake of HIV self-testing among key populations taking HIV pre-exposure prophylaxis in central Uganda | E-poster | C33 |
TUPEC448 | Retesting for HIV on antiretroviral therapy (ART) against policy recommendations: Investigating the impact on sensitivity of self-testing, Blantyre, Malawi | E-poster | C33 |
TUPEC449 | HIV self-testing method preferences among men who have sex with men in Taiwan | E-poster | C33 |
TUPEC450 | Factors influencing HIV self-testing amongst men who have sex with men (MSM) in Singapore - Understanding barriers and motivators using the Protection Motivation Theory (PMT) framework | E-poster | C33 |
TUPEC451 | HIV self-testing: Assessing potential to improve efficiency of community-based index case testing in Mwenezi district, Zimbabwe | E-poster | C33 |
TUPEC452 | Value of secondary distribution of HIV self-test kits to male partners of female sex workers | E-poster | C33 |
TUPEC453 | Value of secondary distribution of HIV self-test kits to male partners of women attending antenatal clinics | E-poster | C33 |
TUPEC454 | Leaving no one behind: Demonstration project of HIV self-testing among men who purchase sex in Indonesia | E-poster | C33 |
TUPEC455 | High feasibility and acceptability for HIV self-testing among men who have sex with men, male sex workers, and transgender people in Nepal | E-poster | C33 |
TUPEC456 | Perceptions of HIV self-testing to support PrEP delivery among Kenyan PrEP users | E-poster | C33 |
TUPEC457 | Facilitators and barriers toward HIV self-testing among transgender women in Mumbai and Delhi, India | E-poster | C33 |
TUPEC458 | Identification of HIV-positive partners and changes in sexual behavior following secondary distribution of HIV self-tests by high-risk women in Kenya | E-poster | C33 |
TUPEC459 | Maternal factors for adherence in infant isoniazid preventive therapy provision among HIV-exposed uninfected infants (HEU) in Kenya | E-poster | C34 |
TUPEC460 | Acceptability and willingness to pay for hepatitis C virus services in Vietnam | E-poster | C34 |
TUPEC461 | Knowledge and attitudes toward human papillomavirus (HPV), HPV vaccine and cervical cancer among female students in Chittagong, Bangladesh | E-poster | C34 |
TUPEC462 | Incidence of sexually transmitted infections among Men who have sex with men in West Africa (CohMSM ANRS 12324-Expertise Francem | E-Poster BU Poster exhibition | C35 |
TUPEC463 | High prevalence of HIV, syphilis and HCV among key populations and their partners: Results from an integrated multiple diseases testing led by community in Vietnam | E-poster | C35 |
TUPEC464 | Variability in comprehensiveness of sexual health care and HIV prevention | E-poster | C35 |
TUPEC465 | Prevalence of sexually transmitted infections in pregnant women and their partners in Porto Alegre, Brazil | E-poster | C35 |
TUPEC466 | Trends for the future: Binational HIV risk patterns among women who inject drugs living on the U.S.-Mexico border | E-poster | C35 |
TUPEC467 | Human papillomavirus type distribution in head and neck: A meta-analysis from infection to cancer among HIV-negative and HIV-positive patients | E-poster | C35 |
TUPEC468 | Using continuous quality improvement interventions to increase the effectiveness of assisted partner notification services in Kisumu, Kenya | E-poster | C36 |
TUPEC470 | Maximizing HIV testing yield through index partner testing using assisted partner notification approach: Implementation progress in Uganda | E-poster | C36 |
TUPEC471 | The 4 youth by youth HIV self-testing contest: A crowdsourced contest to promote HIV self-testing among young people in Nigeria | E-poster | C36 |
TUPEC472 | High rate of peripartum virological suppression and its significant implications for elimination of mother-to-child transmission of HIV in resource-constrained settings of Eastern Cape, South Africa: Population-based cohort study | E-poster | C37 |
TUPEC473 | Approaching eMTCT in Zimbabwe: Expansion of PMTCT services and declining MTCT, 2012-2018 | E-poster | C37 |
TUPEC474 | Why is there still high maternal to infant HIV transmission where PMTCT services are available? Analysis of service data from 77 health facilities in rural and semi-urban Kenya | E-poster | C37 |
TUPEC475 | A systematic review and meta-analysis of HIV incidence during pregnancy and breastfeeding in sub-Saharan Africa | E-poster | C37 |
TUPEC476 | Who seeks safer conception care in rural Uganda? A call for client-centred care for men and women affected by HIV | E-poster | C37 |
TUPEC477 | Committed, effective and consistent leadership for a sustained PMTCT program in Cameroon: The case of the Cameroon baptist convention health board (CBCHB) | E-poster | C37 |
TUPEC478 | Measurement system analysis: HIV rapid test interpretation in prenatal care in Mexico | E-poster | C37 |
TUPEC479 | Association between contraceptive use and PrEP uptake and continuation in adolescent girls and young women in Cape Town, South Africa | E-Poster BU Poster exhibition | C38 |
TUPEC480 | The effect of HIV and antiretroviral treatment on pregnancy rates in the Western Cape province of South Africa: Findings from a health service linkage study | E-poster | C38 |
TUPEC481 | Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention and PrEP implementation preferences among transgender women in Malaysia: A cross-sectional study | E-poster | C40 |
TUPEC482 | Pre-exposure prophylaxis (PrEP) indication, use, and adherence among transgender women in six U.S. cities: Interim findings from the LITE cohort, 2018 | E-poster | C40 |
TUPEC483 | Integration of HIV prevention and primary care for gay, bisexual, and other men who have sex with men in Puerto Rico | E-poster | C41 |
TUPEC484 | Improved partnership stability while participating in a safer conception program - Perspectives from HIV serodiscordant couples in Kenya | E-poster | C42 |
TUPEC485 | “She takes hers and I take mine”: Experiences of HIV serodiscordant couples using safer conception strategies in Thika, Kenya | E-poster | C42 |
TUPEC486 | How better predict MSM becoming HIV-infected in West Africa? A combined approach of sexual behavior (CohMSM ANRS 12324 - Expertise France) | E-poster | C43 |
TUPEC487 | Quality of health care for key population: Mixed method study among service providers using Donabedian model | E-poster | C43 |
TUPEC488 | Expanding HIV testing among hard-to-reach populations through index testing | E-poster | C43 |
TUPEC489 | Innovative HIV testing strategy with Burundian female sex workers: Enhanced peer outreach approach to improve case detection by comparing outcomes between recruitment chains of HIV-positive and unknown HIV serostatus peers | E-poster | C43 |
TUPEC490 | Characteristics of younger MSM and association of age with PrEP awareness and willingness in Brazil, Mexico and Peru | E-poster | C44 |
TUPEC491 | Novel online technology to reach individuals at risk of HIV with HIV testing services in Nepal | E-poster | C44 |
TUPEC492 | Population size estimation of men who have sex with men using online social network multiplier method | E-Poster BU Poster exhibition | C44 |
TUPEC493 | Tailored, adolescent-friendly mobile clinic sexual health services are convenient, trust-building, and highly preferred over conventional clinics: Investigating acceptability of a youth-directed sexual health services in Cape Town, South Africa | E-poster | C45 |
TUPED643 | Clinical and economic benefits of multi-disease testing on GeneXpert platform in a public health system in Malawi: An observational study | E-poster | D20 |
TUPED644 | Integrated TB/HIV care and treatment improves outcomes among children and adolescents living with HIV | E-poster | D20 |
TUPED645 | Regional progress in achieving 75% reduction in AIDS-related TB deaths: Will we achieve the 2020 target? | E-poster | D20 |
TUPED646 | Chronic HIV and Non-Communicable Diseases (NCD) care management in Uganda: An observation study to describe provision of basic services | E-poster | D21 |
TUPED647 | Community-based case finding for tuberculosis & HIV integrated with non-communicable diseases in KwaZulu-Natal, South Africa | E-Poster BU Poster exhibition | D21 |
TUPED648 | Substance use services in HIV clinics: Data from the global IeDEA consortium, 2014 and 2017 | E-poster | D21 |
TUPED649 | Modeling the cost-effectiveness of antenatal dual HIV/syphilis testing in in Kenya | E-poster | D22 |
TUPED650 | Evaluation of a dedicated postnatal contraception clinic for women living with HIV (WLWH): 5 years post-implementation | E-poster | D22 |
TUPED651 | Factors influencing potential adoption of PrEP services in title X-funded family planning clinics in the Southern United States | E-poster | D22 |
TUPED652 | Integrating family planning services into HIV care in Zambia: Baseline results | E-poster | D22 |
TUPED653 | Effects of peer counseling intervention on access and use of sexual and reproductive health services in women living with HIV in Nepal: A prospective cohort study | E-poster | D22 |
TUPED654 | Examining early postpartum uptake of contraceptives among women with HIV in the context of family planning and HIV services integration in South Africa | E-poster | D22 |
TUPED655 | Community intervention partners (CIPs), an innovative cost effective model to promote behavioral change among HIV positive drug abusers in Wakiso District, Uganda | E-poster | D23 |
TUPED656 | Implementation of integrated patient-centered care for women presenting late with advanced HIV disease in Nigeria | E-poster | D23 |
TUPED657 | In the aftermath of AIDS denialism era in South Africa: Perspectives and outcomes of integrated PMTCT services at primary health care level | E-poster | D23 |
TUPED658 | Tracking integrated malnutrition and HIV outcomes: Cohort analysis of integrated service provision, Gweru district, Zimbabwe | E-poster | D23 |
TUPED659 | Integrating health services provision - Improving HIV testing and treatment for children under five years referred to rural health facilities with severe acute malnutrition | E-poster | D23 |
TUPED660 | Intervention to reduce the Cervical Cancer Screening Gap in women with HIV from the Condesa Iztapalapa Specialized Clinic in Mexico City | E-poster | D23 |
TUPED661 | Understanding the financial lives of female sex workers in Addis Ababa, Ethiopia: Implications for economic strengthening interventions for HIV prevention | E-poster | D24 |
TUPED662 | Mobile client driven DSD: Strategies employed to support continuity of HIV treatment among mobile clients | E-poster | D25 |
TUPED663 | Increased rate of antiretroviral-resistance associated mutations in Human Immnunodeficiency Virus infecting Mexicans with a background of stay in a foreign country | E-poster | D25 |
TUPED664 | Factors associated with increased social deprivation among older people living with HIV (PLHIV) | E-poster | D28 |
TUPED665 | The prevalence of current alcohol use and risky drinking among patients receiving antiretroviral therapy in Dar es Salaam, Tanzania | E-poster | D28 |
TUPED666 | Community advisory boards role in accelerating optimal HIV treatment | E-poster | D29 |
TUPED667 | The grantees as catalysts for collaborative governance in HIV/AIDS care and treatment in the U.S.: The EMAs' experience | E-poster | D29 |
TUPED668 | Leveraging a novel HIV/Syphilis Duo assay to increase diagnoses among female sex workers at drop-in centres in Cameroon | E-poster | D30 |
TUPED669 | Uptake and performance of blood-based self-testing versus oral fluid-based self-testing in Blantyre district, Malawi | E-poster | D30 |
TUPED670 | “Knowing One's Truth” - user and non-user experiences with HIV self-testing in Kenya: A qualitative study | E-poster | D30 |
TUPED671 | Index HIV self-testing among male partners in Malawi: Predictors of self-testing within a randomized controlled trial | E-poster | D30 |
TUPED672 | Complexity outside the box: Challenges faced by HIV rapid diagnostic tests in a non-profit testing program in Mexico | E-poster | D30 |
TUPED673 | Acceptability of Cepheid Xpert HIV-1 Qual assay (Xpert HIV) in early infant diagnosis | E-poster | D30 |
TUPED674 | Uptake and utilization of viral load test results for improved patient management in selected facilities in Central Uganda | E-poster | D33 |
TUPED675 | Low invalid rates observed with point-of-care CD4 testing in decentralized high HIV burden settings | E-poster | D32 |
TUPED676 | Feasibility of point-of-care viral load testing in postpartum HIV-positive women in South Africa: Interim results | E-poster | D32 |
TUPED677 | The acceptability of introducing rapid tests for HIV and sexually transmitted infections in the real-world: A systematic review of qualitative research | E-poster | D32 |
TUPED678 | Acceptability of point-of-care viral load testing to facilitate differentiated HIV care: A qualitative study amongst people living with HIV and healthcare workers in South Africa | E-poster | D32 |
TUPED679 | Availability of HIV point-of-care diagnostic tests in rural Ghana's primary healthcare clinics: An audit of inventory management | E-poster | D32 |
TUPED680 | Economic analyses of hepatitis C responses: Charting the paths, costing the steps | E-poster | D34 |
TUPED681 | The journey to self-reliance: Sustainable economic empowerment in Namibia | E-poster | D34 |
TUPED682 | Implementation of WHO plant to use integrase inhibitors in first-line HIV treatment: Middle-income setting experience | E-poster | D34 |
TUPED683 | Sustainability of mHealth interventions: Patients´ preferences and willingness to pay user fees for mHealth ART adherence support tool in resource limited setting | E-poster | D35 |
TUPED684 | Willingness to accept/willingness to pay ratios of prevention of mother-to-child transmission services in a Nigerian hospital: A cross-sectional contingent valuation study | E-poster | D35 |
TUPED685 | Health systems effects of strengthening human resource for HIV service delivery in pre-service training institutions: Experience from a government-NGO-donor collaboration in Nigeria | E-poster | D38 |
TUPED686 | HIV funding in the Republic of Congo: Assessment of free care | E-poster | D39 |
TUPED687 | Transitioning from international funding to domestic health financing to support key population-led health services in Thailand: The Songkhla model | E-poster | D40 |
TUPED688 | Pay-it-forward integrated HIV/STD testing for men who have sex men: A mixed methods pragmatic study | E-poster | D40 |
TUPED689 | Increasing the efficiency and cost-effectiveness of HIV community outreach through pay-for-performance | E-poster | D40 |
TUPED690 | Determinants of willingness to participate in community-based health insurance among people living with HIV in a large tertiary hospital in South-east Nigeria | E-poster | D40 |
TUPED691 | DTG or not to DTG? Health-system stakeholder perceptions on Dolutegravir to optimise guideline implementation in Zimbabwe | E-poster | D41 |
TUPED692 | Changing sexual dynamics among young men in Mumbai, India - need for innovative prevention strategies | E-poster | D41 |
TUPED693 | Effectiveness of a 5-point modular training program for health providers in achieving holistic care for PLHIV who use drugs in the Philippines: A pilot study | E-poster | D42 |
TUPED694 | A cross-sectional study on levels of knowledge on provision of second-line antiretroviral therapy in Malawi in 2016 | E-poster | D42 |
TUPED695 | An assessment of health care facilities compliance to environmental and social safeguards - a case study of HIV/AIDs programme development project II (HPDP II) Nigeria | E-poster | D43 |
TUPED696 | Improving HIV/AIDS response coordination in Nigeria through the use of the Geographic Information System (GIS) | E-poster | D43 |
TUPED697 | What IF? Implementation fidelity (IF) for improving HIV program performance in Zimbabwe | E-poster | D43 |
TUPED698 | Accelerating implementation of HIV-related stigma and discrimination reduction activities in healthcare settings: A learning network approach in Cambodia, Lao PDR, Thailand, and Vietnam | E-poster | D43 |
TUPED699 | Improving rapid ART initiation in Blantyre, Malawi, through implementation of a quality improvement collaborative | E-poster | D43 |
TUPED700 | Improved HIV testing efficiency in Zambia through enhanced real-time program surveillance | E-poster | D43 |
TUPED701 | Ensuring real-world comparability in a pragmatic implementation trial of eHealth HIV prevention intervention for young men who have sex with men (YMSM) | E-poster | D43 |
TUPED702 | Using KP-MoH integrated service delivery approach to promote MSM comprehensive HIV service uptake among MSMs in Machakos County | E-poster | D44 |
TUPED703 | Stigma and discrimination in key population in the health sector: The Mozambique experience | E-poster | D44 |
TUPED704 | Factors promoting uptake of drop-in center services by female sex workers in Thika, Kenya | E-poster | D44 |
TUPED705 | Male engagement - effective strategy towards Reduction of Socio-structural barriers to ART adherence and retention among females in North West Nigeria | E-poster | D44 |
TUPED706 | Clinic-level factors influencing the decision to adopt trauma-informed care in HIV primary care settings | E-poster | D44 |
TUPED707 | Caregivers' representations of and attitude towards people living with HIV/AIDS | E-poster | D44 |
TUPED708 | Moral barriers for HIV/AIDS prevention and care among men who have sex with men: Challenges in times of conservatism in Brazil | E-poster | D44 |
TUPED709 | Police occupational health as an element of HIV risk environment: Factors predicting needle stick injury in the line of duty | E-poster | D46 |
TUPED710 | The cost-effectiveness of evidence-based HIV testing interventions in six US cities | E-poster | D47 |
TUPED711 | Expanded access to patient-level TB/HIV (big) data opens doors to enhance data utilization and improve data quality | E-poster | D48 |
TUPED712 | Quality improvement approach to influence quality health care services for children and adolescents in wakiso district health facilities | E-poster | D48 |
TUPED713 | Harmonizing community prevention data in the National Prevention Database (NPD) system in Cambodia | E-poster | D49 |
TUPED714 | Data actualization: A methodology to periodically monitor and update the reported number of patients active on ART | E-poster | D50 |
TUPED715 | Determining the utilization of the electronic patient management system (EPMS) for patient management and care - an implementation fidelity approach to strengthening health systems | E-poster | D50 |
TUPED716 | Impact of eHealth platforms and enhanced surveillance in strengthening, evaluating and improving performance in HIV programs: Evidence from the Zambian EQUIP program | E-poster | D50 |
TUPED717 | Improving data collection processes and reporting efficiencies in large HIV programs | E-poster | D50 |
TUPED718 | Factors influencing self-perceived threat of HIV and other STI acquisition and decision-making around voluntary testing among gay, bisexual and other men who have sex with men: A conceptual framework | E-Poster BU Poster exhibition | D51 |
TUPED719 | Moving from 'it's impossible' to possible: Using REDCap to successfully manage studies using the multiphase optimization strategy (MOST) and other multicomponent intervention studies | E-poster | D52 |
TUPED720 | Use of 'Design Thinking' tools to enhance the design process of user-centered interventions focused on HIV: A comparative case study | E-Poster BU Poster exhibition | D52 |
TUPED721 | 'The woman gives': Exploring gender and relationship factors in HIV advance care planning among African American caregivers | E-poster | D53 |
TUPED722 | HIV prevention decisions by at-risk young women in South Africa: Proposing a novel Integrated behavioral journey framework using a mixed methods research approach | E-poster | D53 |
TUPED724 | 'Either you float or you drown:' Social ties, stigma, and lived experiences of the HIV care continuum in HPTN 065 | E-poster | D54 |
TUPED725 | The acceptability of Combined Community Engagement Strategies Study (ACCESS): Results of a novel pilot for extending community feedback on HIV clinical trials | E-poster | D56 |
TUPED726 | Community engagement in HIV key populations hotspots mapping and size estimation in Nigeria | E-poster | D56 |
TUPED727 | Young MSM and heterosexual men's high acceptability of long-acting implants and injections for HIV prevention in South Africa: Results of a discrete-choice experiment | E-poster | D57 |
TUPED728 | Mental health and retention in HIV services among adults initiating antiretroviral therapy in Tanzania | E-poster | D59 |
TUPED729 | Mental health outcomes of an intervention to improve ART adherence among MSM living with HIV in Mexico | E-poster | D59 |
TUPED730 | Influence of stigma and discrimination on psychosocial health in children affected by AIDS in Nepal: A cross-sectional study | E-poster | D59 |
TUPED731 | How youth living with HIV in Uganda experience stigma: Results of a photovoice study | E-poster | D59 |
TUPED732 | Experienced stigma, mental health, and life outlook: Select data from a quality of life survey of PLHIV in five fast-track cities | E-poster | D59 |
TUPED733 | Psychosocial variables related to serostatus disclosure to couples in Mexican people with HIV | E-poster | D60 |
TUPED734 | Real lived experiences of being LGBTI and HIV positive | E-poster | D60 |
TUPED735 | “Not a walking piece of meat with disease”: Undetectability and quality of life among HIV-positive gay, bisexual and other men who have sex with men in the U=U era | E-poster | D61 |
TUPED736 | A grounded theory of HIV-Stig H ma among youth living with IV in Western Uganda | E-poster | D62 |
TUPED737 | “We should choose or decide. You know, we're the ones that are here”: Selecting community-based research priorities in aging with HIV | E-poster | D63 |
TUPED738 | Ageing of HIV epidemic in India: Insights from HIV estimation modelling under National AIDS Control Programme | E-poster | D63 |
TUPED739 | Loneliness among older people living with HIV: Why the “older old” are less lonely than the “younger old” | E-poster | D63 |
TUPED740 | “There's no retirement plans for us”: Re-analysis from a qualitative study of HIV-positive MSM who use substances | E-poster | D63 |
TUPED741 | “Communication, compatibility, compromise, and commitment
we allow ourselves the room to grow and change”: Qualitative findings from Canadian gay, bisexual and men who have sex with men in current HIV-serodifferent relationships | E-poster | D64 |
TUPED742 | I want to be like you: A case study of individual and group peer counseling for women in Mexico | E-poster | D64 |
TUPED743 | The next generation: Pregnancy outcomes in adolescents and women living with perinatally acquired HIV in South Africa | E-poster | D65 |
TUPED744 | Are we covered? Family planning uptake and needs among women on ART in Zimbabwe | E-poster | D65 |
TUPED745 | Reasons for contraceptive discontinuation among HIV-infected Ugandan women on depo-provera and tenofovir-based ART | E-poster | D65 |
TUPED746 | Adolescent hormonal contraception use and childbearing ideation in the era of HIV - Findings from a large community-based study in South Africa | E-poster | D65 |
TUPED747 | High daily tobacco smoking participation among Australian HIV-positive gay and bisexual men | E-poster | D67 |
TUPED748 | Cognitive functioning and driving ability in HIV-infected professional drivers | E-poster | D67 |
TUPED749 | HIV-infected women: Medical co-morbidities and rates of virologic suppression | E-poster | D67 |
TUPED750 | Acceptability of a smartphone-based music intervention for chronic pain and problematic opioid use among patients living with HIV | E-poster | D68 |
TUPED751 | HIV struggles: Conceptualizing human rights (HR) and how to implement them | E-poster | D70 |
TUPED752 | Temporal trends in HIV-related self-reported stigma in the African Cohort Study, 2013-2018 | E-poster | D70 |
TUPED753 | Educational attainment and HIV risk among young adults, Rakai, Uganda 1996 - 2013 | E-poster | D70 |
TUPED754 | Social capital needs of young Black gay, bisexual and other men who have sex with men living with HIV in Atlanta, USA | E-poster | D70 |
TUPED755 | The social-structural syndemic in Nepal: Cross-border movement, incarceration, and poor access to harm reduction programs fuel the HIV and hepatitis C epidemic among people who inject drugs | E-poster | D70 |
TUPED756 | Correlates of antiretroviral adherence among people living with HIV engaged in peer-to-peer HIV counseling in Myanmar | E-poster | D70 |
TUPED757 | Assessing perceived impacts of climate change on HIV health among HIV-infected smallholder farmers in the Nyanza region of Kenya | E-poster | D70 |
TUPED758 | Divergent preferences for HIV testing services among young people in Nigeria: A choice experiment | E-poster | D70 |
TUPED759 | HIV-related stigma, neighborhood poverty, and viral load suppression among men who have sex with men in Atlanta, Georgia, USA | E-poster | D70 |
TUPED760 | What about housing? Understanding a constant hurdle for Latinx PLWH in San Francisco, CA | E-poster | D70 |
TUPED761 | Social vulnerability, syndemics and the continuum of HIV care among people living with HIV/AIDS in Brazil | E-poster | D71 |
TUPED762 | High levels of social and structural adversity among disabled HIV-positive adult caregivers of young people living with HIV: Implications for HIV programming | E-poster | D72 |
TUPED763 | Characteristics of intersectional stigma and effects on HIV testing uptake among Black MSM in the United States | E-poster | D72 |
TUPED764 | Who are the men who pay for sex in Mozambique? Results from the National HIV/AIDS Indicator Survey (IMASIDA) 2015 | E-poster | D74 |
TUPED765 | Mediators of the relationship between transactional sex and incident HIV infection among young women in South Africa enrolled in HPTN 068 | E-poster | D74 |
TUPED766 | Being young and on the move in sub-Saharan Africa: How 'waithood' exacerbates HIV risks and disrupts the success of current HIV prevention interventions | E-poster | D75 |
TUPED767 | High HIV positive yield among clients of female sex workers in the context of socio-political unrest in Bamenda, Cameroon | E-poster | D76 |
TUPED768 | The end is still too far: Human rights violations among people living with HIV and AIDS enrolled in a semi-urban health center in Kenya | E-poster | D76 |
TUPED769 | Childhood and adulthood exposure to violence linked to HIV risk behaviors among men in Eswatini | E-poster | D76 |
TUPED770 | Characterizing the relationship between violence and HIV infection among sex workers across 10 countries in sub Saharan Africa | E-poster | D76 |
TUPED771 | Police abuse, ART adherence, and harm reduction among PWID living with HIV in Ukraine | E-poster | D76 |
TUPED772 | Sexual violence and HIV risk in the bridging population of men who have sex with both men and women: Longitudinal data from four countries of West Africa | E-poster | D77 |
TUPED773 | Redressing violence among female sex workers through crisis response system: Experience from a community-led HIV prevention intervention in India | E-poster | D77 |
TUPED774 | Association between forced sexual initiation, sexual risk behaviours and HIV status among young people in Botswana: A cross-sectional study | E-poster | D77 |
TUPED775 | Assessing the risk of incarceration on time to first injection initiation assistance provision among a cohort of people who use drugs in Vancouver, Canada | E-poster | D78 |
WEAA0101 | Decreased ex vivo T cell proliferation and increased immune exhaustion in early treated and long-term suppressed HIV-infected pre-adolescents from the CHER trial: Implications for cure strategies | Oral abstract session with live Q&A | A11 |
WEAA0102 | Immune activation markers and CMV DNA-aemia in children with perinatally acquired HIV infection | Oral abstract session with live Q&A | A10 |
WEAA0103 | Deep sequence analysis of HIV adaptation following vertical transmission: Importance of human leucocyte antigen-driven selection on the evolution of HIV | Oral abstract session with live Q&A | A8 |
WEAA0104 | No evidence of HIV-1 evolution in circulating reservoirs in children during more than six years of early suppressive antiretroviral therapy despite detectable levels of cell associated-HIV-RNA | Oral abstract session with live Q&A | A1 |
WEAA0105 | Oral TLR7 agonist administration induces an immunostimulatory response in SIV-infected ART-suppressed infant Rhesus macaques | Oral abstract session with live Q&A | A25 |
WEAA0201 | Longitudinal dynamics of follicular CD4+ T cells in acute SIV infection | Oral abstract session with live Q&A | A8 |
WEAA0202 | HIV gp120-mediated CD4+T cell activation is inhibited by non-neutralizing gp120-V2 loop antibodies | Oral abstract session with live Q&A | A10 |
WEAA0203 | Tandem bispecific antibody prevents fully and induces prolonged T cell immunity against pathogenic SHIV in monkey models | Oral abstract session with live Q&A | A37 |
WEAA0204 | Bone marrow stromal antigen-2 (bst-2) gene variants associate with HIV-1 control in black South African individuals | Oral abstract session with live Q&A | A27 |
WEAA0205LB | Early ART initiation in acute HIV infection generates long-lived memory HIV-specific CD8+ T cells endowed with efficient proliferative and cytolytic recall response | Oral abstract session with live Q&A | A8 |
WEAA0301 | Sting agonist as a kick and kill agent to target the HIV reservoir | Oral abstract session with live Q&A | A23 |
WEAA0302 | Different regimens of Romidepsin administration for reversion of SIV latency in a rhesus macaque model of complete virus control | Oral abstract session with live Q&A | A23 |
WEAA0303 | Fingolimod treatment at ART initiation delays SIV rebound after ART interruption | Oral abstract session with live Q&A | A24 |
WEAA0304 | Vesatolimod (GS-9620) is safe and pharmacodynamically active in HIV-infected individuals | Oral abstract session with live Q&A | B52 |
WEAA0305LB | Safety and virologic effect of the HIV-1 broadly neutralizing antibodies, VRC01LS or VRC07-523LS, administered to HIV-infected adults in a phase 1 clinical trial | Oral abstract session with live Q&A | A37 |
WEAB0101 | Targeted screening and immediate start of treatment for acute HIV infection decreases time between HIV diagnosis and viral suppression among MSM at a Sexual Health Clinic in Amsterdam | Oral abstract session with live Q&A | B1 |
WEAB0102 | Same-day antiretroviral therapy initiation in Thailand: Different models and initial outcomes from scale-up in five provinces in Thailand | Oral abstract session with live Q&A | B49 |
WEAB0103 | Treatment outcome among patients on ART in Southern Tanzania: Does time of ART initiation matter? | Oral abstract session with live Q&A | B49 |
WEAB0104 | High acceptability and feasibility of same-day antiretroviral therapy services among HIV-positive adolescents in Bangkok, Thailand | Oral abstract session with live Q&A | B49 |
WEAB0105 | “Test and treat” approaches to HIV care may affect the Xpert MTB/RIF testing impact in high burden TB/HIV settings: Results from a cohort from a rural hospital in Southern Mozambique | Oral abstract session with live Q&A | B16 |
WEAB0201 | Describing the characteristics and long-term outcomes of adolescents living with perinatally acquired HIV in the IeDEA-Southern Africa Collaboration: 2004-2017 | Oral abstract session with live Q&A | B69 |
WEAB0202 | Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV-infected children receiving first line anti-retroviral therapy | Oral abstract session with live Q&A | B67 |
WEAB0203 | Dolutegravir containing regimens may need optimization for African youth failing ART | Oral abstract session with live Q&A | B12 |
WEAB0204 | Cognitive function among cART-treated children and adolescents with HIV in Zambia: Results from the HIV-associated neurocognitive disorders in Zambia (HANDZ) study | Oral abstract session with live Q&A | B73 |
WEAB0205 | Response to direct acting antivirals in vertically HIV/HCV co-infected youths | Oral abstract session with live Q&A | B71 |
WEAB0301 | Improved survival for people living with HIV, with and without tuberculosis, over time in Latin America | Oral abstract session with live Q&A | B16 |
WEAB0302 | Social network characteristics are associated with prevalent tuberculosis infection among people living with and without HIV in nine communities in rural Uganda | Oral abstract session with live Q&A | B16 |
WEAB0303 | HCV reinfection among HIV/HCV co-infected individuals in Europe | Oral abstract session with live Q&A | B18 |
WEAB0304 | Evaluation of hepatitis C virus rapid diagnostic test in HCV mono- and HCV/HIV co-infected patients from low and middle income countries | Oral abstract session with live Q&A | B18 |
WEAB0305 | Prevalence, characteristics and outcomes of patients with Cryptococcal meningitis in Maputo, Mozambique | Oral abstract session with live Q&A | B15 |
WEAB0306 | HPV genotyping is as important as cytology in anal cancer early diagnosis | Oral abstract session with live Q&A | B21 |
WEAB0401LB | Pharmacokinetics of dolutegravir 5mg dispersible tablets in children weighing 6 to < 20kg dosed using WHO weight bands | Oral abstract session with live Q&A | B64 |
WEAB0402LB | MK-8591 at doses of 0.25 to 2.25 mg QD, in combination with doravirine establishes and maintains viral suppression through 48 weeks in treatment-naïve adults with HIV-1 infection | Oral abstract session with live Q&A | B38 |
WEAB0403LB | Switching to DTG+3TC fixed dose combination (FDC) is non-inferior to continuing a TAF-based regimen (TBR) in maintaining virologic suppression through 24 weeks (TANGO Study) | Oral abstract session with live Q&A | B38 |
WEAB0404LB | Durable efficacy of dolutegravir (DTG) plus lamivudine (3TC) in antiretroviral treatment-naïve adults with HIV-1 infection - 96-week results from the GEMINI studies | Oral abstract session with live Q&A | B49 |
WEAB0405LB | The ADVANCE trial: Phase 3, randomized comparison of TAF/FTC/DTG, TDF/FTC/DTG or TDF/FTC/EFV for first-line treatment of HIV-1 infection | Oral abstract session with live Q&A | B38 |
WEAB0406LB | ANRS 170 QUATUOR 4/7 days maintenance strategy in antiretroviral treated adults with HIV-1 infection: an open randomised parallel non-inferiority phase III trial | Oral abstract session with live Q&A | B41 |
WEAC0101 | Transmission Linkages among persons with incident HIV-1 infection in North Carolina, 2014-2018 | Oral abstract session with live Q&A | C10 |
WEAC0102 | Applications of HIV genetic networks in Mexico: Implications for prevention | Oral abstract session with live Q&A | C10 |
WEAC0103 | High burden of recent and prevalent HIV infection among men who have sex with men (MSM) in Hanoi, Vietnam | Oral abstract session with live Q&A | C3 |
WEAC0104 | Acute HIV infection among individuals who start PrEP: The ImPrEP experience, a demonstration project in the context of combination prevention in Brazil, Mexico and Peru | Oral abstract session with live Q&A | C27 |
WEAC0105 | HIV incidence among men who have sex with men and transgender women in Tijuana, Mexico | Oral abstract session with live Q&A | C3 |
WEAC0201 | Does the use of HIV self-testing kits lead to unintended effects? Evidence from female sex workers in Malawi | Oral abstract session with live Q&A | C33 |
WEAC0202 | Closing the testing gap: High uptake of HIV self-testing among men in rural and peri-urban KwaZulu-Natal, South Africa | Oral abstract session with live Q&A | C33 |
WEAC0203 | Peer-mobilized HIV self-testing increases case detection and linkage to ART among key populations in Burundi | Oral abstract session with live Q&A | C33 |
WEAC0204 | Community-led HIV self-testing, with and without assistance, successfully reaches key populations and their partners in Viet Nam | Oral abstract session with live Q&A | C33 |
WEAC0205 | Social-media based secondary distribution of HIV self-testing among Chinese men who have sex with men: A pilot implementation program assessment | Oral abstract session with live Q&A | C33 |
WEPDB0101 | Evolution of HIV drug resistance surveillance in Brazil: A declining trend to celebrate | Poster exhibition | B44 |
WEPDB0102 | Thresholds of pre-treatment HIV-1 drug resistance indicate regions for priority actions in the antiretroviral therapy program of Cameroon | Poster exhibition | B44 |
WEPDB0103 | Prevalence and predictors of etravirine resistance mutations in HIV-positive individuals failing second-line antiretroviral therapy in Uganda | Poster exhibition | B44 |
WEPDB0104 | HIV-1 drug resistance and third-line outcomes among children and adolescents failing second-line therapy in Malawi | Poster exhibition | B67 |
WEPDB0105 | HIV-1 drug resistance surveillance among parturient women on anti-retroviral therapy in the Eastern Cape, South Africa: Implications for elimination of mother-to-child transmission | Poster exhibition | B44 |
WEPDB0106 | Going beyond guidelines: HIV-1 drug resistance testing at low-level viremia, a South African experience | Poster exhibition | B12 |
WEPDC0101 | #HIVSelfTest: A social media campaign to promote HIV self-testing among young people in Nigeria | Poster exhibition | C44 |
WEPDC0102 | Developing a novel mobile app to support HIV testing and PrEP uptake among young MSM: The LYNX Study | Poster exhibition | C36 |
WEPDC0103 | Stigma and online sex-seeking among men who have sex with men and transgender women in Tijuana, Mexico | Poster exhibition | C36 |
WEPDC0104 | Transgender-led social media interventions effectively identify transgender woman subpopulations with substantial risk of HIV acquisition and successfully link to HIV prevention, care and treatment services | Poster exhibition | C44 |
WEPDC0106 | Pilot study of a gamified, social networking app shows improvements in PrEP adherence among YMSM in the US | Poster exhibition | C46 |
WEPDC0107 | Digitizing interventions: An internet-based approach to reach out to the 'hidden network of men who have sex with men' in Mumbai, India | Poster exhibition | C44 |
WEPDC0201 | Healthcare providers' attitudes and experiences delivering oral PrEP to adolescent girls and young women: Implementation research to inform PrEP rollout in Kenya, South Africa, and Zimbabwe | Poster exhibition | C27 |
WEPDC0202 | Providers' attitudes towards and experiences with oral pre-exposure prophylaxis (PrEP) implementation in the SEARCH trial in Kenya and Uganda | Poster exhibition | C27 |
WEPDC0203 | Implementation challenges and strategies in integration of PrEP into maternal and child health and family planning services: Experiences of frontline healthcare workers in Kenya | Poster exhibition | D1 |
WEPDC0204 | Surmounting PrEP delivery challenges through adaptation of implementation guidelines: Lessons learned from HIV care clinics in Kenya | Poster exhibition | C27 |
WEPDC0205 | Training, communication, and prescribing patterns of pre-exposure prophylaxis (PrEP) among a sample of nurse practitioners in the United States: Important gaps and opportunities | Poster exhibition | D5 |
WEPDC0206 | Attitudes, confidence and knowledge towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among healthcare providers in Thailand | Poster exhibition | C27 |
WEPEA041 | In-depth transcription profile comparison of multiple primary cell HIV latency models | E-Poster BU Poster exhibition | A19 |
WEPEA042 | Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ART | E-poster | A19 |
WEPEA042 | Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ART | E-poster | A19 |
WEPEA043 | Galectin-1 promotes HIV-1 latency reactivation | E-poster | A20 |
WEPEA044 | Cellular modulation and HIV reactivation in response to serial treatment of latently HIV-infected CD4 T cells with Histone Deacetylase inhibitors (HDACi) | E-poster | A20 |
WEPEA045 | Cell-penetrating inhibitors of the Hsp70 chaperone activity can prevent HIV-1 reactivation from latency | E-poster | A20 |
WEPEA046 | Specific characteristics of certain CD4 T cell subsets are related to HIV reservoir size | E-poster | A20 |
WEPEA047 | Two decades of antiretroviral therapy provide no evidence for re-seeding of the HIV DNA reservoir by ongoing viral replication | E-poster | A21 |
WEPEA048 | Effector memory cells are the main contributors to the replication-competent HIV reservoir in ART-suppressed individuals | E-poster | A21 |
WEPEA049 | ICOS is preferentially expressed by productively infected cells in the blood and lymph nodes from HIV-infected individuals | E-poster | A21 |
WEPEA050 | The CARMA study - children on early suppressive therapy: Total HIV-1 DNA quantitation 12 years post ART initiation | E-poster | A21 |
WEPEA051 | Variable overlap in HIV-1 env sequences obtained from plasma virus after analytical treatment interruption and viral outgrowth assay | E-Poster BU Poster exhibition | A22 |
WEPEA052 | Kansui, an ingenol-containing herbal supplement, safely induced CD8, NK, and monocyte activation in three ART-suppressed SIVmac251-infected rhesus macaques | E-poster | A22 |
WEPEA053 | Large in vivo expansion and subsequent partial contraction of a T cell clone carrying a defective HIV genome reflect the dynamics of the HIV reservoir during ART | E-poster | A22 |
WEPEA054 | Viral dynamics during suppressive ART - Towards HIV elimination from reservoirs | E-poster | A22 |
WEPEA055 | Latency reactivating agents: Impact on human macrophages physiology and susceptibility to HIV-1 infection | E-poster | A23 |
WEPEA056 | Discovery and mechanistic study of novel suppressors of post-integrated HIV expression from African natural products | E-poster | A23 |
WEPEA057 | Development of Cytotoxic Enhancing Agents (CEAs) to improve shock-and-kill strategies | E-poster | A23 |
WEPEA058 | Human endogenous retrovirus expression landscape in models of HIV-1 latency | E-Poster BU Poster exhibition | A23 |
WEPEA059 | CD8 depletion plus signaling of the non-canonical NF-kB pathway reverses latency in SIV-infected, ART-suppressed rhesus macaques | E-poster | A23 |
WEPEA060 | The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cells | E-poster | A23 |
WEPEA061 | Regulation of Cas9 by viral proteins REV and TAT for in vitro inactivation of HIV-1 proviral DNA | E-poster | A23 |
WEPEA062 | Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after cART interruption in humanized mice | E-poster | A24 |
WEPEA063 | A glycosyl phosphatidylinositol-anchored anti-HIV antibody neutralizes HIV-1 replication in dendritic cell-T cell cocultures through both cis and trans mechanisms | E-poster | A26 |
WEPEA064 | CRISPR/Cas9 targeting HIV-1 regulatory genes inactivates latent proviral DNA and prevents new infection in T cell culture with inhibition of viral escape | E-poster | A26 |
WEPEA065 | Allogeneic stem cell transplant in HIV-1 infected individuals; An update of the IciStem Consortium | E-poster | A26 |
WEPEA066 | Rapamycin immune tolerization enables gene transfer following subcutaneous delivery of AAV6 but not CD4-retargeted AAV6 vectors in AAV-seropositive rhesus macaques | E-poster | A26 |
WEPEA067 | HLA B27 and HLA B57 alleles in HIV-infected long term non progressor children | E-poster | A27 |
WEPEA068 | High frequency of activated Treg and Th17 cells in HIV elite controllers | E-poster | A27 |
WEPEA069 | Breastfeeding and mother-to-child transmission of HIV: Contribution of breast milk miRNA | E-poster | A28 |
WEPEA070 | Sterol metabolism modulates susceptibility to HIV-1 Infection in HESNs | E-poster | A28 |
WEPEA071 | Endoplasmic reticulum associated aminopeptidases 2 (ERAP2) is released in the secretome of activated MDM and reduces in vitro HIV-1 infection | E-poster | A29 |
WEPEA100 | Oral cART hu-PBMC mouse model to study HIV persistent infection | E-poster | A52 |
WEPEA101 | Role of gut microbiota on vaccine response in HIV exposed Infants | E-poster | A52 |
WEPEB279 | Highly diverse anaerobe-predominant vaginal microbiota among pregnant women with HIV in Zambia | E-poster | B58 |
WEPEB280 | Pregnancy outcomes among HIV-positive women on dolutegravir versus efavirenz-based antiretroviral therapy: Week 48 analysis of the ADVANCE trial | E-poster | B58 |
WEPEB281 | Impact of isoniazid and pregnancy on efavirenz pharmacokinetics in women living with HIV | E-poster | B58 |
WEPEB282 | Comparison of adverse birth outcomes among HIV-infected and HIV-uninfected women in the era of universal ART in Malawi: A registry study | E-poster | B58 |
WEPEB283 | Vaginal progesterone to prevent preterm delivery among pregnant women with HIV in Zambia: A pilot feasibility study | E-poster | B58 |
WEPEB284 | Monitoring and supporting women living with HIV who choose to breastfeed their HIV-exposed infants in Botswana | E-poster | B58 |
WEPEB285 | Failure to account for delivery phenotype minimizes the apparent effect of HIV on preterm birth | E-poster | B58 |
WEPEB286 | Medroxyprogesterone acetate (MPA) exposure and risk of female-to-male HIV transmission among serodiscordant couples in East and southern Africa | E-poster | B60 |
WEPEB287 | Examining contraceptive use in an urban Ugandan HIV clinic after the dolutegravir safety alert | E-poster | B60 |
WEPEB288 | Symptom burden and inflammatory cytokines in persons living with HIV in the US: An analysis by sex and menopause stage | E-poster | B61 |
WEPEB289 | Assessing gaps in comprehensive HIV and women's health care across a typology of care for women living with HIV in Canada | E-poster | B62 |
WEPEB290 | Validation of self-reported combination antiretroviral therapy (cART) regimens in a multi-site Canadian cohort of women living with HIV | E-poster | B62 |
WEPEB291 | HIV positivity trends among HIV-exposed children tested on point-of-care early infant diagnosis in Mozambique | E-poster | B63 |
WEPEB292 | Analysis to change public health strategy in the diagnosis investigation of children exposed to HIV in Brazil | E-poster | B63 |
WEPEB293 | Innovations in index case contact testing to improve the identification of HIV-infected children and adolescents | E-poster | B63 |
WEPEB294 | Virological suppression in children after switch to a Raltegravir-containing regime in Brazil: A real life study | E-poster | B67 |
WEPEB295 | The youth peer mentor role in supporting adolescent HIV care: A qualitative study | E-poster | B67 |
WEPEB296 | Providing childhood TB care in a high prevalence HIV/TB setting: The experience of Baylor College of Medicine in Eswatini | E-poster | B67 |
WEPEB298 | Pediatric anti-retroviral therapy (ART) and care of HIV-infected children in Myanmar: Gaps and challenges | E-poster | B67 |
WEPEB299 | Time to viral load suppression and rebound among Canadian infants and children initiating cART in the Early Pediatric Initiation Canada Child Cure Cohort (EPIC4) Study | E-poster | B67 |
WEPEB300 | Children's perceptions of HIV cure research: An end of study assessment of the Early Pediatric Initiation, Canada Child Cure Cohort (EPIC4) study | E-poster | B68 |
WEPEB301 | Outcomes of children and adolescents living with HIV considered lost to follow up at IeDEA-SA cohorts in the Western Cape: Linkage to Western Cape Provincial Health Data Centre records | E-poster | B69 |
WEPEB302 | Twelve-month outcomes among paediatric and adolescent patients initiated on ART from 2007 to 2016 in Nigeria: A retrospective cohort study | E-poster | B69 |
WEPEB304 | In utero/early life anti-retroviral exposure related changes in socioemotional adjustment indices by 6-10 years of life in HIV exposed Ugandan children | E-poster | B73 |
WEPEB305 | Mental health and its association with metabolic outcomes in youth living with perinatally acquired HIV in the Cape Town Adolescent Antiretroviral Cohort (CTAAC) | E-poster | B73 |
WEPEB306 | Developmental defects of enamel in primary dentition after in utero TDF exposure | E-poster | B74 |
WEPEB307 | Patient characteristics associated with viral suppression do not predict patient confidence in the healthcare transition process among youth living with HIV | E-poster | B75 |
WEPEB308 | Perinatally HIV-infected adolescents transition to adult care: A natural experiment | E-poster | B75 |
WEPEB310 | High incidence of syphilis in transgender women in Buenos Aires, Argentina | E-poster | B79 |
WEPEB311 | Transgender-led same-day antiretroviral therapy services at the Tangerine Community Health Center in Bangkok, Thailand | E-poster | B79 |
WEPEB312 | Prevalence and consequences of gender affirmation procedures done outside of medical care among transwomen in São Paulo, Brazil | E-poster | B79 |
WEPEB313 | Predictors of increased carotid intimal media thickness among transgender women: A cross-sectional study | E-poster | B79 |
WEPEB314 | Risk of polypharmacy and inappropriate prescribing in persons living with HIV ≥ 65 years of age | E-poster | B82 |
WEPEB315 | Improved HIV care in incarcerated individuals via telemedicine in Pennsylvania, United States | E-poster | B82 |
WEPEC494 | Provision of residual drug level results from the dapivirine ring open label extension study: Participant reactions and explanations during a qualitative ancillary study (MTN 032) | E-poster | C46 |
WEPEC495 | HIV pre-exposure prophylaxis (PrEP) dosing preference and reported use in the EPIC-NSW trial | E-poster | C46 |
WEPEC496 | HIV prevention in men who have sex with men as inferred from their adherence to daily versus event-driven pre-exposure prophylaxis: Cross-over clinical trial | E-poster | C46 |
WEPEC497 | A self-administered scale for assessing adherence of men who have sex with men to pre-exposure prophylaxis | E-poster | C46 |
WEPEC498 | Prevalence of HIV testing, unrecognized HIV infection and ART uptake among key population in India: Findings from a large-scale multi-centric cross-sectional surveillance survey | E-poster | C46 |
WEPEC499 | Role of support groups in promoting pre exposure prophylaxis (PREP) adherence among men who have sex with men (MSM) in Hoymas Clinic Nairobi, Kenya | E-poster | C46 |
WEPEC500 | Effect of DREAMS interventions on HIV risk among out-of-school adolescent girls and young women (AGYW) with higher and lower HIV vulnerability: Results from Malawi | E-poster | C47 |
WEPEC501 | Using the one stop shop (OSS) based point of service (POS) strategy for effective prevention, care and treatment to key populations (KP) in Nasarawa State, Nigeria | E-poster | C47 |
WEPEC502 | Sexual behaviour and perceived HIV risk among HIV-negative members of serodiscordant couples | E-poster | C48 |
WEPEC503 | The syndemic of alcohol/drug use and violence victimisation and its effects on HIV transmission risk among transgender women: Cross-sectional, population-based study in India | E-poster | C49 |
WEPEC504 | Depression among HIV-positive female sex workers in Malawi is associated with prior treatment default, experience of violence, and low income | E-poster | C49 |
WEPEC505 | Understanding high-risk injection practices among people who inject drugs following the closure of a rural syringe services program | E-poster | C53 |
WEPEC506 | Evaluating impact of harm reduction on the HIV epidemic among people who inject drugs in China | E-poster | C53 |
WEPEC507 | Comparative analysis of effectiveness of HIV testing modalities among PWID in Ukraine | E-poster | C53 |
WEPEC508 | Characteristics of buprenorphine injecting drug abuser in Bandung; a cross-sectional study | E-poster | C53 |
WEPEC509 | Heroin use and sexual risk behaviours among HIV/HCV co-infected methadone patients in Myanmar | E-poster | C53 |
WEPEC510 | Using a multiple approach to increase uptake of HIV testing services among adolescent girls and young women: TASO Mbarara | E-poster | C54 |
WEPEC511 | Engaging adolescent girls and young women in HPTN 082: Lessons learned | E-poster | C54 |
WEPEC512 | HIV testing and treatment among adolescents and young people in a high burden district with annual home-based HIV testing: Findings from the Chókwè Health Demographic Surveillance System (CHDSS), Mozambique, 2014-2017 | E-poster | C54 |
WEPEC513 | Risky sexual behavior among in-school adolescents participating in the Girls Achieve Power Trial in South Africa: Intervention considerations for high HIV prevalence settings | E-poster | C54 |
WEPEC514 | Shifts in HIV-risk outcomes among adolescent girls and young women (AGYW) in Kenya | E-poster | C54 |
WEPEC515 | Empowering adolescent girls and young women to remain HIV-free: Outcomes of a DREAMS HIV self-testing and PrEP combination prevention intervention targeting AGYW and male partners | E-poster | C54 |
WEPEC516 | Impact of a community-level combination HIV prevention intervention on knowledge of HIV status amongst adolescents: Primary results of HPTN 071 (PopART) for Youth Study | E-poster | C54 |
WEPEC517 | Getting to first 90: Factors associated with ever being tested for HIV among transgender women, intersex, and Hijras who have sex with men reached online in India: Implications for intervention | E-poster | C55 |
WEPEC518 | Developing a model to prioritise male-to-female transgendered people/Hijras for differentiated prevention services in targeted interventions in India | E-poster | C55 |
WEPEC519 | Factors associated with condom use with non-commercial partners among transgender women in Cambodia: Findings from a national survey using respondent-driven sampling | E-poster | C55 |
WEPEC520 | Combined mobile and static clinic approach to increase HIV testing and positive yield for transgender population in Lahore, Pakistan | E-poster | C55 |
WEPEC521 | Low PrEP uptake but good retention among transgender women: Preliminary results from real-world PrEP roll-out in Vietnam | E-poster | C55 |
WEPEC522 | Why intervention among migrants is required for enhancing HIV/AIDS prevention responses in India? A study of National AIDS Control Programme | E-poster | C56 |
WEPEC523 | Sustaining safe sex behavior among female sex workers by addressing their vulnerabilities and strengthening community-led organizations in India | E-poster | C57 |
WEPEC524 | Unintended HIV prevention outcomes of a cash transfer trial on child development in East Zimbabwe: Evidence from a cluster-randomised trial and general-population survey | E-poster | C57 |
WEPEC525 | Achieving the first two 90s of 90-90-90 target of female sex workers: Impact of peer educators' model in Malawi | E-poster | C57 |
WEPEC526 | Barriers and facilitators of uptake of minimum prevention package intervention (MPPI) by men who have sex with men (MSM) in Nigeria | E-poster | C57 |
WEPEC527 | Updating national guidelines to scale up PrEP implementation: The Taiwan experience | E-poster | C60 |
WEPED776 | Predictors of anticipated healthcare stigma among adult men who have sex with men in the United States and across sub-Saharan African countries | E-poster | D81 |
WEPED777 | Use of enhanced peer mobilizers to increase MSM reach for HIV clinical services in Zimbabwe | E-poster | D81 |
WEPED778 | Condomless intercourse with female partners among bisexual male sex workers in the Dominican Republic: A social network analysis | E-poster | D81 |
WEPED779 | Depressive symptoms and substance use: Changes overtime among a cohort of HIV-positive and HIV-negative MSM | E-poster | D81 |
WEPED780 | Depressive symptoms as a predictor of HIV seroconversion among young adult African-American/Black men and transgender women who have sex with men in the Southeastern United States | E-poster | D81 |
WEPED781 | HIV care cascade in men who have sex with other men in Paraguay 2017: Combination of epidemiological surveillance data studies with laboratory data | E-poster | D81 |
WEPED782 | Understanding low rates of HIV testing among men in Colombia: Findings from a population-based survey | E-poster | D81 |
WEPED783 | Low viral suppression among HIV-positive men who have sex with men in Mpumalanga, South Africa | E-poster | D81 |
WEPED784 | HIV testing by MSM peer educators: High HIV-positive yield among MSM living in Yaoundé tested by Humanity First Cameroon | E-poster | D81 |
WEPED785 | Assessing sexual event-level substance use and risk behavior for HIV infection in a diverse sample of HIV-negative MSM in the era of PrEP, 2018 | E-poster | D81 |
WEPED786 | Perceived barriers to access available HIV and STIs services among men who have sex with men (MSM) in Tanga Region Northern, Tanzania | E-poster | D81 |
WEPED787 | Types of group sex and their association with sexual risk behaviors among HIV-negative men who have sex with men (MSM) | E-poster | D81 |
WEPED788 | Family characteristics in sex communication and social support: Implications for emerging adult men who have sex with men's PrEP engagement | E-poster | D81 |
WEPED789 | Identifying the experiences of young gay, bisexual, and other men who have sex with men who engage in the sexualized use of cannabis | E-poster | D81 |
WEPED790 | “It's easy and convenient!”: Perceived facilitators and barriers for HIV self-testing and PrEP uptake among adolescent men who have sex with men, transgender women and their parents | E-poster | D81 |
WEPED791 | High sexual risk behaviours as a determinant to HIV infection among MSM in Nigeria | E-poster | D81 |
WEPED792 | Risk correlations of intimate partner violence among men who have sex with men in Chengdu, China | E-poster | D81 |
WEPED793 | Perceived barriers to emerging PrEP modalities in the US: Social determinants of health and modality-specific attributes may inhibit PrEP uptake among sexual and gender minority adolescents | E-poster | D81 |
WEPED794 | Understanding expressions of masculinity among HIV-positive, adolescent men who have sex with men in Mexico City | E-poster | D81 |
WEPED795 | Understanding gay couples: A new vision for HIV prevention in Peru | E-poster | D81 |
WEPED796 | Testing the Stall et al´s (2008) theory of syndemic production among MSM in India: Cross-sectional study | E-poster | D81 |
WEPED797 | Informal pain management after reduction/discontinuation in opioid therapy | E-poster | D82 |
WEPED798 | Alcohol, drug use and mood disorders in a random sample of HIV positive rural South African men | E-poster | D82 |
WEPED799 | Urgent need to address multiple high-risk behavior and prevent HIV among young PWID | E-poster | D82 |
WEPED800 | Sex work as a mediator between female sex and incident HIV infection among people who inject drugs in Tijuana, Mexico | E-poster | D82 |
WEPED801 | Increased HIV prevalence and risk among women who inject drugs compared to men who inject drugs in Tajikistan | E-poster | D82 |
WEPED802 | Egocentric network and HIV/HCV risk behaviors among drug users on methadone maintenance treatment in Wuhan, China | E-poster | D82 |
WEPED803 | The association between opioid agonist treatment and injection initiation assistance among persons with different injection polydrug use practices in Vancouver, Canada | E-poster | D82 |
WEPED804 | Estimating and reaching drug users with HIV prevention package in Mali | E-poster | D82 |
WEPED805 | Understanding the public health consequences of closing a rural syringe services program in Charleston, West Virginia (USA) | E-poster | D82 |
WEPED806 | Injection drug use association with HIV and sex work stigma in Kenyan sex workers | E-poster | D82 |
WEPED807 | HIV, housing, and health: A case study of the experiences of people living with HIV who use drugs living in two models of supportive housing in Vancouver, Canada | E-poster | D82 |
WEPED808 | A qualitative investigation of HIV treatment dispensing models and impacts on adherence among people living with HIV who use drugs and live in low-income housing | E-poster | D82 |
WEPED809 | Community initiated treatment for HIV-positive people who inject drugs in Ukraine | E-poster | D82 |
WEPED810 | The syndemic of violence victimisation, incarceration, risky injecting behaviours and HIV infection among people who inject drugs: Cross-sectional, population-based study in India | E-poster | D82 |
WEPED811 | Enabling factors for rapid scale-up of services for sex workers in large urban African sites, 2014-2018 | E-poster | D83 |
WEPED812 | Viral load monitoring among FSWs enrolled in the LINKAGES project in Malawi: Progress, challenges, and opportunities | E-poster | D83 |
WEPED813 | Why not PrEP? Evaluation of PrEP refusal and discontinuation among transgender women in Peru | E-poster | D84 |
WEPED814 | Reduction of anxiety, drug and alcohol abuse and increment of quality of life in transgender women after 6 months of initiating HIV treatment | E-poster | D84 |
WEPED815 | "Papi, I take care of myself and take care of you": PrEP communication and disclosure among Latina immigrant transgender women in the Washington DC metropolitan area | E-poster | D84 |
WEPED816 | Burden of PTSD, depression, and anxiety on transgender HIV+ and HIV- persons at key population-led health centers in Bangkok and Pattaya: Mixed methods cross-sectional screening study | E-poster | D84 |
WEPED817 | "I was just concerned about getting pregnancy": Reproductive health decision making among adolescent girls in Thika, Kenya | E-poster | D85 |
WEPED818 | Preventing HIV in adolescent girls and young women: Presentation of Lesotho qualitative results | E-poster | D85 |
WEPED819 | High levels of gender-based violence (GBV) among HIV-positive adolescent girls and young women (AGYW) at antenatal clinics in Malawi highlights need for GBV services | E-poster | D85 |
WEPED820 | Factors associated with HIV seropositivity among male sexual partners of adolescent girls and young women (AGYW) in Tanzania: Findings from a combination prevention program | E-poster | D85 |
WEPED821 | Adolescent girls on PrEP: Findings from Kenya's oral PrEP scale-up supported by Jilinde | E-poster | D85 |
WEPED822 | Motivations for early PrEP discontinuation among Kenyan adolescent girls and young women: A qualitative analysis from a PrEP implementation program | E-poster | D85 |
WEPED823 | Progress towards the UNAIDS 1st 90: A descriptive assessment of pregnant adolescent girls & young women attending antenatal care clinics in 24 districts in Zimbabwe (2017- 2018) | E-poster | D85 |
WEPED824 | Understanding the vulnerabilities of adolescent girls and young women in Oshikoto region, Namibia | E-poster | D85 |
WEPED825 | The effectiveness of the DREAMS eligibility screening: How do we know if we are reaching vulnerable adolescent girls and young women (AGYW) aged 10 - 24? Namibia, 2018 | E-poster | D85 |
WEPED826 | Migrant patients living with HIV/AIDS in Japan: Review of factors associated with high dropout rate in a leading medical institution in Japan: Second report | E-poster | D86 |
WEPED827 | “The doctor told me straight up that 'we hate you'”: Foreign migrant adolescent girls' and young women's access to sexual and reproductive health services in South Africa | E-poster | D86 |
WEPED828 | HIV prevention cascade awareness and engagement among urban refugee and displaced adolescents and youth in Kampala, Uganda | E-poster | D86 |
WEPED829 | Transnationally-tailored interventions improve retention in HIV care and viral suppression among Latino immigrants living in the Continental U.S | E-Poster BU Poster exhibition | D86 |
WEPED830 | Understanding the social structural production of HIV risk among a population of marginalized Latina young women: Prevention efforts among changing risk environments | E-poster | D88 |
WEPED832 | Factors associated with condom use by men in extra marital relationships in Benin | E-poster | D88 |
WEPED833 | "AIDS is our greatest enemy!" A pilot study on a cultural sensitive approach to HIV prevention among Yi (Nuosu) ethnic minority group in Southwest China | E-poster | D88 |
WEPED834 | Sociodemographic characteristics and sexual behaviours among HIV positive and HIV negative adolescents in a primary care setting in Mexico: A case control study | E-poster | D88 |
WEPED835 | Multisite qualitative evaluation of microbicide/PrEP acceptability among mothers and male partners in Africa: The MAMMA study | E-poster | D88 |
WEPED836 | Piloting early detection of HIV, tuberculosis and hepatitis C in probation settings in Ukraine | E-poster | D88 |
WEPED837 | Associations between mental and substance use disorders and virologic failure among adolescents attending antiretroviral therapy clinics in South Africa and Zimbabwe | E-poster | D88 |
WEPED838 | High risk men utilize traditional healers instead of biomedical facilities in southwestern Uganda: Results from a mixed methods study | E-poster | D88 |
WEPED839 | HIV prevention among young key population: Community-based strategy outcomes, Brazil | E-poster | D88 |
WEPED840 | "HIV is much better than diabetes, with HIV you take your pill and that's it!": A qualitative study in three South African provinces | E-poster | D88 |
WEPED841 | “The hardest thing is to return to who I was before the diagnosis”: Gendered stigma among naïve older patients presenting to HIV care in Ukraine | E-poster | D88 |
WEPED842 | Understanding of perceived infectiousness and its influence on sexual behavior among individuals with acute HIV infection in Lilongwe, Malawi (HPTN 062) | E-poster | D89 |
WEPED843 | Enhance peer outreach approached help to penetrate the “Gharana” system and identify new case detection among Hijra (Transgender) in Mumbai, India | E-poster | D89 |
WEPED844 | Willingness to pay for PrEP within high HIV burden counties in Kenya: Results from a population-based survey | E-poster | D89 |
WEPED845 | Factors associated with perceived and current HIV risk among men who have sex with men in Brazil, Mexico and Peru | E-poster | D89 |
WEPED846 | Assessment of the change in sexual and health seeking behaviour of men who have sex with men (MSM) and Transgender/Hijra (TG/H) population | E-poster | D89 |
WEPED847 | Effectiveness of quality improvement on occurrence of needle stick injuries in Harare City, Zimbabwe, 2017: A quasi-experimental study | E-poster | D89 |
WEPED848 | How will eventual HIV cure impact prevention behavior? | E-poster | D89 |
WEPED849 | Perceptions of HIV risk and knowledge of HIV prevention strategies among young minorities recently diagnosed with HIV infection in South Texas, Unites States (U.S.) | E-poster | D89 |
WEPED850 | HIV prevention knowledge gaps on pre-exposure prophylaxis (PrEP) among adolescents and young people aged 15-24: Insights from formative research in two urban communities in Lusaka, Zambia | E-poster | D89 |
WEPED851 | What we know and don't know about adolescent girls and young women and HIV Prevention in sub-Saharan Africa: Analysis of insights across completed, ongoing and planned projects | E-poster | D89 |
WEPED852 | Differences in ART provider expectations and client knowledge about viral load testing in northern Namibia: A qualitative assessment | E-poster | D90 |
WEPED853 | Community ART centres - are they filling the gap and meeting the grade? A comparison of quality and numbers between community-based ART centres and conventional hospitals in Zambia | E-poster | D90 |
WEPED854 | HIV provider and vocational driver knowledge of HAND and needs for health management | E-poster | D90 |
WEPED855 | Occupation and education among youth living with HIV receiving care at two tertiary care hospitals in Bangkok, 2017 | E-poster | D90 |
WEPED856 | Strategic donor investments for strengthening condom markets: The case of Zimbabwe | E-poster | D93 |
WEPED857 | Traditional beliefs on gender roles and HIV risk behaviour among adult men interested in voluntary medical male circumcision, South Africa | E-poster | D94 |
WEPED858 | Acceptability of voluntary medical male circumcision in Zambia: Using population-level data to inform demand-creation strategies | E-poster | D94 |
WEPED859 | The power of habits for sustained high ART adherence and the use of incentives for building them | E-poster | D95 |
WEPED860 | Profile of self-reported adherence to HIV pre‑exposure prophylaxis in Brazil | E-poster | D96 |
WEPED861 | Scaling-up PrEP offer in the Brazilian Unified Health System (SUS) | E-poster | D96 |
WEPED862 | Women's perceived barriers and facilitators towards long-acting injectable pre-exposure prophylaxis (PrEP): Results from six cities across the United States | E-poster | D96 |
WEPED863 | Willingness to screen for pre-exposure prophylaxis in pharmacies among men who have sex with men | E-poster | D96 |
WEPED864 | Acceptability of and preferences for novel HIV pre-exposure prophylaxis (PrEP) delivery methods among sexual and gender minority (SGM) adolescents assigned male at birth in the USA | E-poster | D96 |
WEPED865 | Advancing HIV prevention through public opinion polling: Lessons from the southern United States | E-poster | D96 |
WEPED866 | The negative direct effect of depressive symptoms on PrEP adherence among high-risk South African women In HPTN 067 | E-poster | D96 |
WEPED867 | High and sustained use of a gamified PrEP adherence app (P3: Prepared, Protected, emPowered) among young MSM | E-poster | D96 |
WEPED868 | Multilevel approach in optimizing assisted partner notification services (aPNS): A case study at Awendo Sub County Hospital, Western Kenya; January to August 2018 | E-poster | D90 |
WEPED869 | Knowledge about pre-exposure prophylaxis (PrEP) among sexual and gender minority (SGM) adolescents assigned male at birth in the United States (US) | E-poster | D96 |
WEPED870 | Scale-up of pre-exposure prophylaxis through reorientation of health services in eight districts in Northern Namibia | E-poster | D96 |
WEPED871 | Sexual behavior changes, PrEP and condom use in the ANRS Prevenir study | E-poster | D96 |
WEPED872 | Factors associated with adherence to HIV post-exposure prophylaxis among survivors of sexual assault in the Bojanala District, North West, South Africa | E-poster | D97 |
WEPED873 | Final HIV outcome for exposed infants: Improving mother-baby pair retention in prevention of mother-to-child transmission care in Eswatini through proactive community follow-up | E-poster | D101 |
WEPED874 | Improving adolescent sexual and reproductive health through participatory parent-child communication interventions in rural communities of Eastern Uganda | E-poster | D101 |
WEPED875 | Reducing vulnerability to TB co-infection and morbidity of opportunistic infections from biomass fuel-household air pollution amongst positive women & children in rural households in Kisumu County | E-poster | D101 |
WEPED876 | A qualitative evaluation of the ACCELERATE! initiative: HIV prevention, care and treatment Interventions for Black men who have sex with men | E-poster | D101 |
WEPED877 | Perceptions of ART outreach services in the community among stable and expert HIV-positive clients: A qualitative focus group discussion from Tanzania | E-poster | D101 |
WEPED878 | Reaching the third 90: Differentiated treatment options involving village health workers in rural Zimbabwe | E-poster | D101 |
WEPED879 | Impact of a community-based antiretroviral therapy (ART) delivery program for female sex workers (FSWs) in Tanzania - Results of a quasi-experimental study | E-poster | D101 |
WEPED880 | Long term impact assessment of programme titled Pehchan: “Strengthen community institutions and systems for MSM, Hijra and transgender communities to increase reach and quality of services” | E-poster | D101 |
WEPED881 | Role of WhatsApp in empowering female sex workers in India: Learnings from large scale community-based intervention program in India | E-poster | D101 |
WEPED882 | Champion community centers: A Philippine model for strengthening and scaling up community-based HIV services | E-poster | D101 |
WEPED883 | HIV and sexual health education: An inner city community-based project | E-poster | D101 |
WEPED884 | The ENABLE model: A community-based approach to eliminate mother-to-child transmission of HIV (eMTCT) in rural Eastern Cape, South Africa | E-poster | D101 |
WEPED885 | Advocates in action: Peer supporters driving change on the frontlines of service delivery | E-poster | D102 |
WEPED886 | A qualitative analysis of the link between violence against women and quality of HIV programming in 8 African Countries | E-poster | D102 |
WEPED887 | Holistic demand creation and community mobilisation for PrEP integration into comprehensive sexual reproductive and health (SRH) services for adolescent girls and young women (AGYW) supporting South African National PrEP programme | E-poster | D103 |
WEPED888 | Finding the men that matter most: Creating demand for HIV prevention services among very high-risk men in Zambia | E-poster | D103 |
WEPED889 | Using knowledge exchange platforms with quality improvement (QI) approaches in the Partnership of HIV-Free Survival to improve prevention of mother to child transmission (PMTCT) of HIV services in sub-Saharan Africa | E-poster | D105 |
WEPED890 | Mother-to-child transmission of HIV: A racial phenomenon in Brazil | E-poster | D105 |
WEPED891 | Too little, too late: Early lessons on Maternal MTCT risk from HIV positive infant case investigation in Zimbabwe | E-poster | D105 |
WEPED892 | Routine evidence for informing eMTCT: Early lessons from case-based investigation of newly diagnosed infants 0-24 months in Zimbabwe | E-poster | D105 |
WEPED893 | Predictors of HIV-exposed infant feeding knowledge and counseling practices among health workers´ in a tertiary center in Northern Nigeria | E-poster | D105 |
WEPED894 | Using financial diaries to understand the economic lives of women enrolled in PMTCT in Zomba, Malawi | E-poster | D105 |
WEPED895 | Exploring the conceptual pathways linking savings group participation to medication adherence in Mozambique | E-poster | D106 |
WEPED896 | Preferences for conditional economic incentives to improve adherence to pre-exposure prophylaxis: A discrete choice experiment in Mexico City | E-poster | D106 |
WEPED897 | Cost of cash transfer programs applied to HIV: A systematic review | E-poster | D106 |
WEPED898 | Stigma, trauma, HIV risk: The closure of a rural syringe services program in West Virginia (USA) | E-poster | D110 |
WEPED900 | Civil unrest and late entry into HIV care and impact on HIV-related mortality, Juba Teaching Hospital, South Sudan 2013 - 2018 | E-poster | D112 |
WEPED901 | Challenges in access and quality of care for HCV in Ukrainian women's prisons | E-poster | D112 |
WEPED902 | Mental health systematic evaluation in newly enrolled adults into a third-care level HIV clinic in Mexico City reveals a very high frequency of mental health care needs | E-poster | D112 |
WESY0802LB | Qualitative evaluation of PrEP implementation in Brazil - ImPREP stakeholders study | Oral abstract session with live Q&A | D4 |